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Abstract 
The strength of peptide:MHC interactions with the T cell receptor (TCR) is 
correlated with the time to first cell division, the relative scale of the effector 
cell response, and the graded expression of activation-induced proteins. The 
TCR proximal tyrosine kinase ITK simultaneously influences many 
biochemically separate signaling cascades. T cells lacking ITK exhibit 
selective impairments in effector T cell responses after activation, but under 
the strongest signaling conditions ITK activity is dispensable. To gain insight 
into whether TCR signal strength and ITK activity tune observed graded gene 
expression through unequal activation of disparate signaling pathways, I 
examined NFAT, NF-κB and MAP kinase pathways during early activation of 
individual naïve OT-I CD8+ T cells using peptide-loaded antigen presenting 
cells. Utilizing both measurement of transcription factor translocation in 
single T cell nuclei and conventional phospho-flow cytometry, I observed 
digital activation of Erk-MAPK and NFAT1 at all peptide doses and avidities. 
However, NF-κB activation showed a graded response to variation in TCR 
signal strength and was more sensitive to treatment with an ITK inhibitor. 
Inhibitor-treated cells showed poor induction of AP-1 factors Fos and Fosb, 
NF-κB response gene transcripts, and survival factor Il2 transcripts. ATAC-
seq analysis revealed genomic regions most sensitive to ITK inhibition are 
enriched for NF-κB and AP-1 motifs. Together, these data indicate a key role 
for ITK in orchestrating optimal activation of separate TCR downstream 
pathways, specifically aiding NF-κB activation. More broadly, I describe a 
mechanism by which variation in TCR signal strength can produce patterns 
of graded gene expression in activated T cells. 
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Chapter I: Introduction 
Preface 
 Upon matriculating to the University of Massachusetts Medical School, 
I studied immunology during my undergraduate coursework and also worked 
in multiple immunology laboratories which were seeking a better 
understanding in basic lymphocyte biology. These experiences helped frame 
my goals for my graduate work but also grounded my perspective in the real 
work of a scientist. I entered the graduate program with a sincere interest in 
adaptive immune responses, particularly in the exact details in how mammals 
efficiently generate specific cellular responses to disease; both in the initial 
recognition of a threat and persistent protection due to immunological 
memory.
During my tenure as a graduate student, I had personal goals of 
gaining topical expertise, sharpening my critical thinking skills, and training 
for cross-discipline technical proficiency. The Berg Lab offered overlap in 
many of my academic interests and the mentoring culture within the lab 
encouraged students to explore different and emerging disciplines pertinent 
to current immunobiology. When our questions about CD8+ T cell activation 
were approaching the limit of our cellular-based experimental designs. Dr. 
Berg welcomed my pursuit for answers through computational and genomics 
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approaches, in which her lab lacked extensive experience. Thus, I pursued a 
productive collaboration with Dr. Garber’s laboratory to help me acquire new 
skill sets to diversify my education in immunobiology and intracellular 
signaling transduction with transcriptomics and genomics approaches.
I am confident moving forward equipped with my diversified training in 
pursuing new endeavors of scientific discovery.
Perspective and importance of CD8+ T cell research 
 In the 1950s, we still knew almost nothing about the “small 
lymphocytes.” By 1970, immune cells with potent cytotoxic capability were 
identified and in 1975 attributed to Ly-2 (CD8ɑ) and Ly-3 (CD8β) expressing 
lymphocytes (Masopust et al., 2007). In the mere 45 years since, we have 
amassed a wealth of appreciation for how cytotoxic CD8+ T cell responses 
provide protection during even the most threatening immune challenges. By 
the late 1990s, it was demonstrated CD8+ T cells can be persuaded to act as a 
powerful treatment to combat cancer cells. We also learned when 
dysfunctional, CD8+ responses significantly contribute to autoimmunity and 
to the persistence of chronic infections. Most of these discoveries were made 
possible through simultaneous revelation regarding the molecular workings 
of the T cell receptor (TCR) complex and how it directs the transcriptional 
reprogramming of activated T cells. But the story is still unfinished. 
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 Immunologists today are charged with the task of fully unlocking the 
natural and therapeutic potential of CD8+ T cell responses. As I write in 
autumn of 2020, the world is amidst a global SARS-CoV-2 COVID-19 
pandemic, and the need to study the basic biology of CD8+ T cell responses 
has never been more clear (Le Bert et al., 2020; Weiskopf et al., 2020). Ever-
increasing access to faster computational methods and networking 
algorithms has allowed us to integrate the function of the TCR with its global 
effects on transcription, metabolism, and chromatin remodeling. I believe we 
are in the midst of a personalized medicine revolution with technologies like 
checkpoint blockade inhibitors and patient-derived T cell immunotherapies 
only marking the beginning of possible solutions to pursue that will 
undoubtedly improve the quality of life worldwide. Continued research in the 
fundamental biology of T cells is paramount to maximize the therapeutic 
potential. 
CD8+ T cell activation kinetics 
 Since the discovery that the TCR recognizes linear peptides bound in 
the groove of major histocompatibility (MHC) molecules, immunologists have 
studied how the quality of this specificity dictates T cell responses (Bjorkman 
et al., 1987a, b; Masopust et al., 2007). In mice and humans, mature T cells 
circulate in the blood, continuously entering and exiting lymphoid organs 
17
scanning activated APCs for their cognate antigen. During a model 
lymphocytic choriomeningitis virus (LCMV) infection in mice, it is estimated 
the likelihood an individual naive T cell will activate is about 1 in 1x105. In 
other words, a single mouse contains only about 100-200 cells that are 
capable of recognizing a specific viral peptide (Blattman et al., 2002; Obar et 
al., 2008). Yet only hours after contact and activation, single naive clones 
rapidly divide up to 14 times; an astonishing achievement of metabolic 
reprogramming (Blattman et al., 2002).
Single T cell clones are unlikely to be lone responders during a viral 
challenge. Many different individual T cells seed the polyclonal response 
within lymphoid organs, an environment where clones compete for APC 
contact. While many individual T cell clones may identify a cognate antigen 
and sufficiently activate, unequal distribution of surface peptide:MHC 
molecules, co-stimulatory molecules on APCs, cytokine production, and the 
strength of the interaction between individual clonal TCR molecules and 
peptide:MHC all encourage competition. Through this competitive nature, 
specific clones tend to dominate a polyclonal response - often those with 
highest TCR specificity. TCR signal strength regulates the the peak size of a 
responding T cell population, but does not seem to impact the cytolytic 
capacity of effector cells (Richard et al., 2018; Tscharke et al., 2015). Therefore 
smaller, “subdominant” simultaneously expanded CD8+ clonal populations are 
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also important in providing protection against a diverse array of other 
epitopes and may be helpful in preventing viral escape (Tscharke et al., 2015). 
Curiously, single identical T cell clones transferred into separate animals do 
not all expand to the same degree when challenged (Buchholz et al., 2013). 
This demonstrates the probabilistic nature of T cell activation following 
antigen interactions and robust in vivo CD8+ responses rely on the 
participation of many clones.
Clonal expansion of CD8+ T cell populations during a response scales 
according to multiple factors including the availability of antigen (pathogen 
load and level of expression on APCs) and quality of TCR-peptide:MHC 
interactions (Mayya and Dustin, 2016). One study compared the dose of a 
pathogen, ovalbumin-expressing Listeria monocytogenes (LM-OVA), in mice 
to the precursor frequency of adoptively transferred barcoded OVA-specific 
TCR transgenic (OT-I) naive cells or “fixed” OT-I TCRβ, “free” TCRɑ T cells 
(van Heijst et al., 2009). Under either condition, they reported a consistent 
and “near complete” recruitment of antigen-specific T cells to the spleen 
regardless of the CFU of LM-OVA at inoculation. However, the maximum 
number of expanded clones was directly dependent on the dose of the 
inoculum. Similar results were observed when testing OT-I responses in mice 
infected with strains of Listeria expressing altered variations of OVA peptide 
(Zehn et al., 2009). Mice inoculated with weaker-affinity LM-OVA strains 
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recruited a similar number of OT-I cells as those inoculated with high-
affinity strains. Both low and high-affinity peptides recruited a similar 
number of OT-I cells at early time points, but clonal expansion of OT-I cells 
scaled with the strength of the OVA peptide variant. Some contradictory 
studies analyzing more diverse T cell pools report not all antigen-specific 
precursors are recruited (especially lowest affinity clones), but there is 
consensus that the magnitude of clonal expansion is linked to the intensity of 
T cell stimulation (Tscharke et al., 2015).
Differentiation of T effector and memory cells 
 Expanded clonal CD8+ T cell populations are short-lived. During acute 
LCMV-Armstrong infection in mice, responding T cell populations typically 
peak at day 8, but quickly apoptose and contract to ~10% of maximum 
numbers as the virus is cleared. The remaining T cells persist as memory T 
cells, which have capability to quickly reactivate upon viral rechallenge 
(Kaech and Cui, 2012). Understanding how quiescent naive cells rapidly 
expand into cytotoxic effector phenotype cells and simultaneously generate 
a memory phenotype pool is an area of high research interest where a large 
amount of progress has been made in recent decades.
Effector and memory CD8+ T cells are transcriptionally and 
epigenetically distinct; representing two separate cell fates derived from a 
20
common precursor (Chen et al., 2018; Kaech and Cui, 2012). Recent review of 
effector and memory differentiation classifies previous hypotheses into two 
competing models; an “asymmetric” model and a “progressive” model of 
differentiation (Chen et al., 2018). The asymmetric model of differentiation 
describes that as early as the first division, an activated naive T cell 
asymmetrically segregates cell structures and transcription factors as it 
divides to yield one memory-like daughter cell and one effector-like 
daughter cell (Chang et al., 2007; Chen et al., 2018; Kaech and Cui, 2012). The 
effector precursor is thought to derive from the APC proximal side of the 
parent cell which is receiving strong TCR signaling. The progressive model of 
differentiation proposes a linear path towards final differentiated effector 
and memory states, citing important events such as repeated contact with 
APCs and continued stimulation gradually pushing activated cells through 
memory-like epigenetic states into functional memory and effector cells 
after multiple generations (Chen et al., 2018).
Diversification of clonal T cell progeny into cells with memory and 
effector phenotypes starts quickly after activation. As soon as 4 days after 
LCMV infection, memory precursor cells (MPECs) can be identified by high 
expression of surface IL-7Rɑ and low expression of KLRG1. Conversely, 
terminally differentiated, short-lived effector cells (SLECs) with high 
cytotoxic capacity are KLRG1 high and IL7Rɑ low (Joshi et al., 2007; Kaech 
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and Cui, 2012; Kaech et al., 2003). Both subsets are characterized by specific 
transcription factors that are important in defining their separate 
phenotypes. SLECs are high in T-box transcription factor (Tbet), B-
lymphocyte-induced maturation protein 1 (Blimp1), interferon regulatory 
factor 4 (IRF4), and signal transducer and activator of transcription (STAT4) 
expression, all important in programming effector expansion and function. 
This includes production of granzymes, interferon-gamma (IFN-ɣ), 
interleukin (IL)-12, and IL-2. MPEC phenotypes include increased expression 
of B cell lymphoma (Bcl)6, specific timing of eomesodermin (eomes) 
expression, as well as persistence of “naive”-associated transcription factors 
like T cell factor 1 (TCF1). 
Further transcriptional and epigenetic studies focused on the 
differentiation of effector and memory subsets revealed that memory cells 
resemble a naive cell phenotype. SLECs however, have closed chromatin near 
gene regions that regulate the program of homeostatic proliferation and 
quiescence found in naive and memory cells (Chen et al., 2018; Henning et al., 
2018). Soon after activation, changes in DNA methylation and activating 
histone modifications such as H3K4me3 and H3K29ac help open the 
chromatin near effector-associated gene regulatory regions (e.g. Tbx21, 
Prdm1, Gzma, Gzmb, Ifng, Klrg1) in both MPECs and SLECs (Henning et al., 
2018). By definition, SLECs more efficiently express the gene products 
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encoded by effector gene regions, perhaps due to stronger TCR signals. 
However, SLECs also simultaneously accumulate repressive H3K27ac 
H3Kme3 histone modifications around naive and memory-associated gene 
regions (e.g. Tcf7, Foxo1, Klf2), which permanently closes this chromatin and 
prescribes terminal differentiation. 
MPECs transition to memory cell states after infection and many of 
the naive-like gene regions remain open. However, they differ from naive 
cells in that many effector-associated gene regions remain open. This has a 
major advantage upon reinfection, where activated memory cells can quickly 
start transcribing effector genes without extensive chromatin remodeling 
(Chen et al., 2018; Kersh et al., 2006). For example, naive CD8+ T cells express 
a high amount of Dnmt1, a methyltransferase that helps maintain methylation 
and suppression of the Ifng locus. Memory cells have lower expression of 
Dmnt1 and Ifng is more easily transcribed upon reactivation (Chen et al., 2018; 
Kersh et al., 2006; Lee et al., 2001).
TCR signal strength control tunes T cell activation and 
differentiation 
 A primary area of research interest in our lab is to understand how 
TCR signal strength directs different outcomes of the effector and memory 
differentiation during activation. As discussed above, the amount of the TCR 
signaling experienced early during activation scales the magnitude of the 
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CD8+ T cell response. Early studies suggested that weak TCR signals produce 
a small memory pool that has poor performance upon rechallenge (Daniels 
and Teixeiro, 2015). This may be true if very immunodominant epitopes are 
present during infection, because high-affinity clones outcompete low-
affinity clones for antigen and during recall immunodominant clones again 
usually expand more greatly which further narrows the protective TCR 
repertoire (Busch et al., 1998; Daniels and Teixeiro, 2015). However, later 
studies examining only low-affinity epitopes revealed clones that poorly 
expand terminal effectors during the primary response produce capable and 
protective memory cells. To test this, Bevan and colleagues inoculated OT-I-
transferred mice with altered OVA peptide-expressing Listeria strains 
(representing a gradient of peptide affinity for the OT-I TCR) (Zehn et al., 
2009). As expected, low-affinity Listeria strains induced both smaller effector 
and memory pools. 138 days later they re-challenged the same mice with 
Vesicular Stomatitis Virus (VSV) expressing native OVA (high-affinity) 
peptide. The few memory cells derived from the low-affinity primary 
response expanded comparably to memory cells derived from a high-affinity 
primary response, indicating low-affinity interactions can produce functional 
and protective memory responses.
While TCR signal strength regulates the overall scale of clonal 
expansion, the Berg lab and others have explored how it also modulates the 
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ratio of terminal effectors to memory precursors (Kaech and Cui, 2012). 
Generally, stronger TCR signals increase the percentage of SLECs relative to 
MPECs (Joshi et al., 2007). TCR control of the SLEC to MPEC ratio is not 
absolute as other factors such as the amount cytokine signaling (IFN-ɣ, IL-12) 
also contribute, but effector cytokine expression is also proportional to the 
amount of initial TCR signal (Cui et al., 2009; Obar et al., 2008).
Graded gene expression in response to graded TCR signals. 
 The Berg lab and others have demonstrated that IRF4, an important 
effector-associated transcription factor, is expressed in a graded manner in 
response to graded TCR signaling (Man et al., 2013; Nayar et al., 2014; 
Raczkowski et al., 2013; Yao et al., 2013). In a 2014 publication, the Berg lab 
modulated TCR stimulation strength using different affinity peptides in a P14 
transgenic mouse model and reported graded levels of IRF4 (Nayar et al., 
2014). In the same study, to engineer graded levels of IRF4 within T cells, our 
lab used Irf4 sufficient, heterozygous floxed (Irf4+/fl), or homozygous floxed 
(Irf4fl/fl) mice. After LCMV infection, the number of effector cells expanded 
during infection scaled according to the “dose” of IRF4 expressed in each 
condition. Others, continuing to explore the role of IRF4, revealed that IRF4 
activity is key in transcribing metabolic reprogramming in activating T cells 
(Man et al. 2013). These revelations about IRF4 helped put it at the center of 
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our focus connecting graded TCR signaling inputs to the previously observed 
transcriptional effects regulating the scale of clonal expansion. 
 In response to these studies, our lab was then focused on uncovering 
the TCR signaling mechanisms that coordinate graded IRF4 expression. My 
colleague James Conley designed experiments that revealed differential gene 
expression in response to graded TCR signaling. Using an OT-I mouse model 
and altered OVA-peptides defined by Bevan and colleagues (Zehn et al., 
2009), preliminary data suggested that the activation marker CD69 had a 
sharp threshold of activation and its response was “all-or-none” or digital in 
nature. Under the same conditions, IRF4 consistently appeared graded. 
Weaker TCR stimulation, achieved by using lower concentration of peptide or 
by using lower affinity peptide, consistently reduced the positive fraction of 
T cells digitally expressing CD69, but dampened the amount of IRF4 
expressed within each CD69+ T cell. Under certain stimulation conditions, 
CD69 expression was the same as those cells stimulated with high-affinity 
peptide, yet IRF4 expression was almost halved. These experiments have 
recently been published (Conley et al., 2020). Our interpretation of this 
phenomenon has changed since initial observations, but at the time it caused 
us to hypothesize about how nuances in TCR downstream signaling pathways 
could produce the graded IRF4 expression we observed in otherwise digitally 
activated cells.
26
TCR machinery and signal initiation 
 A key feature of TCR signaling is its ability to discriminate between 
minute differences in peptide:MHC quality and density. The antigen 
specificity of the TCR is derived from alpha and beta chain pairs. The variable 
(V), diversity (D) and joining (J) gene loci in these chains are rearranged 
during development in the thymus to produce T cell clones with unique TCR 
regions that interact with peptide-loaded MHC molecules. TCR alpha and 
beta dimers associate with CD3 molecules, transmembrane proteins with 
important cytoplasmic signaling domains, to form the TCR complex. Also co-
expressed at the mature T cell surface is either the CD8 or CD4 co-receptor, 
which stabilizes contacts with MHCI or MHCII molecules respectively. 
The “affinity” of a given TCR clone for a particular peptide:MHC 
complex is manifested in the frequency at which contacts are made and 
unmade. The “on-rate” (kon) and the “off-rate” (koff) of TCR and peptide:MHC 
interactions measure an equilibrium that spans many orders of magnitude in 
possible values. A reductionist viewpoint could be that TCR “signal strength,” 
or at least the external factors that contribute to it, is attributed to a 
biochemical equilibrium predominantly defined in the off-rate. Peptides that 
elicit higher functional avidity in CD8+ T cells (more IFN-ɣ, IL-12, etc.) 
consistently have properties of long off-rates. Long measured koff has been 
shown to be the primary contributor to affinity and an excellent predictor for 
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CD8+ protective capacity in human immunotherapies (Nauerth et al., 2013). 
TCRs on immature T cells undergoing selection in the thymus with lower koff 
are also more likely destined for T regulatory cell (Treg) differentiation (Li 
and Rudensky, 2016). The highest-affinity TCR interactions may require only 
a single peptide loaded MHC molecule on an APC cell surface to initiate 
signaling and activate a single T cell (Altan-Bonnet and Germain, 2005; 
Huang et al., 2013). But while the spectrum of TCR off-rates include 
differences in several orders of magnitude, the mechanisms that actually 
permit sensing of discrete differences in TCR binding are thought to be 
found in the rate-limiting biochemistry within the cell.
The kinetic proofreading model of TCR signaling initiation provides a 
mathematical framework to explain how T cells discriminate between small 
differences in agonists (Chakraborty and Weiss, 2014; Rosette et al., 2001). 
This model is rooted in the idea that multiple, reversible biochemical 
intermediates are downstream of TCR ligation. Within T cells, ATP-driven 
phosphorylation and de-phosphorylation of these signaling intermediates 
provide rate-limiting forward progression of signal. This effectively 
exaggerates the small differences between off-rates of peptide:MHC and the 
TCR. Multiple TCR molecules can participate to add to the rate of the 
productive signal, thus higher concentration of low-affinity peptides can also 
yield productive signals. Kinetic proofreading is a way to link the spectrum of 
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potential TCR signaling strength with precise regulation of downstream 
signal propagation within T cells.
The rate-limiting signaling intermediates that are proximal to the TCR 
are bathed in an environment of kinases and phosphatases battling for 
equilibrium. Simply, TCR ligation creates an environment that promotes 
kinase activity and makes phosphatase activity unfavorable. A deeper 
understanding about how this is achieved has required years of kinetic 
Adapted from Li & Rudensky, Nature Reviews Immunology (2016)
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Figure 1.1. Summary of proximal TCR signaling. 
The TCR complex, comprised of TCR ⍺ and β chains, and CD3 molecules (ε, ɣ, 𝜁) interacts with a tigen 
peptide presented on MHC class I molecules on the surface of APCs. Co-receptor (CD8 or CD4) 
stabilizes these interactions by directly contacting MHC molecules. After antigen contact, 
conformational changes promote phosphorylation of CD3 cytoplasmic tails by active Lck. Further 
phosphorylation of LAT by Lck and Zap70 allow for scaffolding by adapter molecules such as SLP76 
and GADs. This allows recruitment of active ITK, which can catalyze phosphorylation of PLC-ɣ1. Active 
PLC-ɣ1 digests stores of membrane bound PI 2 molecules into two second messenger molecules: 
DAG and IP3, which are released to influence downstream signaling. PRN-694 is a small covalent 
inhibitor of ITK kinase activity. Adapted from Li and Rudensky, 2016.
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modeling and examination of the TCR proximal biochemical players, with 
much of the focus to include three important events: activation of Lck, 
Zap70, and LAT. 
In response to TCR ligation, one of the main roles of the Src kinase Lck 
is to phosphorylate cytosolic immunoreceptor tyrosine-based activation 
motifs (ITAMs) on the tails of CD3 class molecules. Evidence suggests that up 
to 40% of Lck is constitutively active in resting T cells, yet under these 
conditions CD3 ITAMs do not maintain active phosphorylation states. 
Further, the phosphatase CD45 can de-phosphorylate ITAMs up to 20 times 
faster than Lck can phosphorylate it (Hui and Vale, 2014). Thus, many studies 
have explored how TCR ligation promotes an environment for enhanced Lck 
efficiency. First, CD3 tails are normally hidden in the plasma membrane at 
steady state and ITAMs are less available for phosphorylation by Lck. TCR 
ligation with peptide:MHC mechanically pulls at the TCR, creating shear 
forces that cause conformational changes releasing CD3 tails from the 
plasma membrane into the cytosol. Second, Lck associates with T cell 
coreceptors CD8 or CD4. When a T cell finds an APC presenting a cognate 
peptide, TCRs and coreceptors form microclusters, thus Lck is placed at 
close proximity CD3. Third, TCR ligation and microcluster formation at the 
synapse pulls the opposing APC cell membrane close to the T cell membrane 
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which forces segregation of bulky phosphatases (such as CD45) away from 
the vicinity of CD3, allowing for kinase activity of Lck to predominate. 
Lck is regulated by two tyrosine phosphorylation sites; Y394 and Y505. Lck 
auto-phosphorylation of residue Y394 activates the kinase domain. The 
inhibitory residue Y505 is primarily phosphorylated by the tyrosine kinase 
Csk, which then locks the protein conformation in an inactive form. Removal 
of Y505 phosphorylation is catalyzed by phosphatases like CD45 and allows 
for an open, primed conformation. However, CD45 can also dephosphorylate 
the activating Y394 residue, thus can be seen to have dual regulatory 
function. Antagonistic regulation of Lck phosphorylation states are found in 
equilibrium, where TCR stimulation ultimately tips the balance of the Lck 
pool toward active states (Chakraborty and Weiss, 2014; Gaud et al., 2018).
Lck phosphorylation of CD3 ITAMs recruits the kinase Zap70, which is 
subsequently phosphorylated also by Lck and other active Zap70 molecules. 
An important role of active Zap70 is to phosphorylate tyrosine residues on 
linker for activation of T cells (LAT), a membrane-bound protein that extends 
into the cytosol. Both LAT and other proteins like Slp76 provide scaffolding 
for many other important adaptor molecules (e.g. Grb2, GADS, Vav1). LAT and 
Slp76 also recruit important signaling molecules IL-2 inducible T cell Kinase 
(ITK) for phosphorylation by Lck and the substrate for ITK, phospholipase-C-
gamma-1 (PLC-ɣ1) (Fig. 1.1).
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Signal transduction downstream of PLC-ɣ1  
 Activation of PLC-ɣ1 triggers numerous downstream pathways and is 
recognized as an important node in T cell activation and signal propagation 
(Fig. 1.2). PLC-ɣ1 digests molecules of phosphatidylinositol 4,5-bisphosphate 
(PIP2) lipids in the plasma membrane into two “second messenger” signaling 
products: diacyl glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) (Smith-
Garvin et al., 2009). DAG production influences multiple separate 
downstream signaling cascades including mitogen-activated protein kinase 
(MAPK) and nuclear factor-kappa (NF-κ)B. Generation of IP3 initiates a 
process called store-operated calcium signaling (SOCE) within T cells. IP3 
binds to the IP3 receptor (IP3R) on the membrane of the endoplasmic 
reticulum, which causes ER release of calcium (Ca2+) into the cytosol. STIM 
molecules in the ER membrane sense this drop of luminal Ca2+ and then 
associate and open calcium (CRAC) channels in the T cell plasma membrane, 
causing a massive influx of extracellular Ca2+ into the cytoplasm, leading to 
calcineurin activation and ultimately nuclear factor of activated T cells 
(NFAT) activation (Smith-Garvin et al., 2009; Trebak and Kinet, 2019). 
Two NFAT (NFAT1 & NFAT4) proteins are constitutively expressed in 
resting naive T cells and restricted to localization in the cytoplasm. Upon 
Ca2+ flux during active signaling, calcineurin phosphatase activity removes 
numerous inhibitory phosphates on NFAT proteins and allows nuclear import 
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and subsequent NFAT-dependent gene transcription (Macian, 2005; Trebak 
and Kinet, 2019). Within seconds after TCR stimulation induces Ca2+ flux, 
NFAT dephosphorylation and translocation behavior is digital - rapid and 
near complete (Marangoni et al., 2013; Podtschaske et al., 2007). Nuclear 
export of NFAT is much slower, on the order of minutes (Marangoni et al., 
2013). Some of the experiments I present here in this dissertation further 
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Figure 1.2. Summary of TCR downstream signaling pathways. 
After produced by PLC-ɣ1, DAG and IP3 influence activation of numerous transcription factor 
pathways. The three major pathways examined here are NF-κB, MAPK, and NFAT. To activate NF-κB, 
DAG activation of PKC-θ influences assembly of the CARMA1-BCL-10-MALT1 (CBM) complex, which 
can activate the IKK complex. Active IKK allows for ubiquitylation and degradation of inhibitory IκB, 
releasing NF-κB dimers (e.g. p65-p50) for translocation to the nucleus. DAG also aids in MAPK 
pathway activation by activating RasGRP which contributes to the pool of active Ras, setting off a 
signaling cascade including Raf, MEK, and Erk1/2. The MAPK pathway terminates with many 
functions, which includes activation of AP-1 transcription factors. The other second messenger 
generated by PLC-ɣ1 activation, IP3, causes intracellular Ca2+ flux via store-operated calcium entry 
(SOCE). Downstream of Ca2+ entry, calcineurin rapidly de-phosphorylates sequestered NFAT 
molecules, which then is permitted to translocate to the nucleus. Adapted from Li and Rudensky, 
2016.
33
affinity and concentration regulate the kinetics of the responding population 
(Gallagher et al., 2018). 
 One of primary effects of PLC-ɣ1 dependent DAG production is 
activation of the MAPK signaling cascade. Extracellular signal-related kinases 
1 and 2 (Erk1/2), exhibit strong digital activation in response to TCR ligation 
(Altan-Bonnet and Germain, 2005). A pivotal studiy in 2009 revealed digital 
Erk activation is made possible through a positive feedback signal mechanism 
(Das et al., 2009). DAG production from PLC-ɣ1 was important in seeding 
active Ras protein, but they showed son-of-sevenless (SOS)-mediated Ras 
activation was the trigger for the the digital switch. 
 Canonical NF-κB activation is mediated by DAG signaling to PKC-Θ, 
which activates the CBM complex, then the IKK complex, and finally 
degradation of inhibitor of κB (IκB)alpha to release NF-κB proteins for 
translocation in the nucleus for transcriptional activity (Lucas et al., 2004; 
Smith-Garvin et al., 2009). A 2010 study reported that NF-κB activation in 
naive T cells exhibited digital switching (Kingeter et al., 2010). However, as 
discussed in Chapter III of this dissertation, this conclusion is incomplete, 
and NF-κB activation behavior in T cells is more nuanced. Previous studies 
have revealed that NF-κB also is regulated by Ca2+ levels (Dolmetsch et al., 
1997; Ishiguro et al., 2006; Podtschaske et al., 2007). Further, more recent 
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investigations into the nuance of PMA and ionomycin stimulation of T cells 
shows synergistic effects on NF-κB transcriptional activity (Brignall et al., 
2017). Together, it seems that the NF-κB pathway is not solely dependent on 
DAG as it is often depicted. 
 NFAT, MAPK, and NF-κB signaling make up a core group of critical 
signaling transduction pathways in T cells (Smith-Garvin et al., 2009). To 
date, few studies have examined all of these pathways simultaneously in 
activating cells (Dolmetsch et al., 1997; Podtschaske et al., 2007). Moreover, 
fewer have stimulated T cells with peptide antigen, but rather use chemical 
or anti-CD3 stimulation. The experiments in this study used OT-I and OVA 
peptides to do exactly that (Zehn et al., 2009). In addition, as ITK catalyses 
PLC-ɣ1, I explored the role plays ITK in tuning all of these pathways.
ITK structure, function, and control of TCR signaling. 
 Since its discovery, understanding the role of the ITK has been a 
principal focus in the Berg Lab (Gibson et al., 1993; Heyeck and Berg, 1993; 
Siliciano et al., 1992; Tanaka et al., 1993; Yamada et al., 1993). ITK is the 
predominant TEC kinase expressed in T cells (Berg et al., 2005). Early 
knockout experiments demonstrated that ITK is important for robust T cell 
activation after TCR stimulation (Andreotti et al., 2018; Andreotti et al., 2010; 
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Liao and Littman, 1995; Schaeffer et al., 1999). Littman and colleagues showed 
that Itk-/- mice have marked decrease in thymic development of single 
positive CD4 T cells (Liao and Littman, 1995). In the same study, Itk-/- both 
CD4+ and CD8+ T cells with transgenic TCRs had defects in thymic 
development and proliferation after TCR stimulation, but not after PMA and 
ionomycin chemical stimulation, indicating ITK activity is important in 
proximal TCR signaling. 
To identify the biochemical role ITK and the other TEC kinase 
expressed in T cells, Rlk, play in proximal TCR signaling, Schwartzberg and 
colleagues compared TCR stimulation of Itk-/-, Rlk-/-, and Itk-/- Rlk-/- mice 
(Schaeffer et al., 1999). After anti-CD3 stimulation, all mutant mice displayed 
defects in proliferation, expression of activation markers such as CD25, and 
low secretion of IFN-ɣ compared to WT. Comparing Itk-/- and Rlk-/- mice 
clearly demonstrated a greater importance of ITK activity over Rlk activity, as 
many Rlk-/- phenotypes were minimal. Significant defects in survival of Itk-/- 
mice after infection with the intracellular parasite Toxoplasma gondii, 
highlighted the in vivo relevance of ITK activity. Importantly, measurement of 
downstream Ca2+ signaling and MAPK signaling events in Itk-/-Rlk-/- T cells 
provided evidence that Tec kinases phosphorylate PLC-ɣ1.
Similar to other Tec kinases, ITK protein contains a kinase domain, a 
Src homology (SH)2 domain, a SH3 domain, and a pleckstrin homology-Tec 
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homology (PHTH) domain. The SH2-SH3 cassette allows for association with 
phosphorylated SLP76 molecules. The PHTH domain recognizes 
phosphatidylinositol (3,4,5)-triphosphate (PIP3) lipids, helping recruit ITK to 
the plasma membrane. In signaling T cells, active PI3 kinase (PI3K) produces 
membrane PIP3 and increased phosphorylation state of SLP76 draws ITK 
molecules close to the kinase-dominant TCR proximal environment and the 
LAT signalosome, where PLC-ɣ1 can associate. 
 Exactly how TCR stimulation produces a dynamic range of responses 
defined by distinct gene expression patterns is still not completely 
understood; however, it is clear that the three main signaling pathways 
leading to transcriptional activation downstream of the TCR: MAPK, NF-κB, 
and Ca2+/NFAT — are critical for much of this regulation. 
Thesis Objectives 
 The projects presented in this dissertation were initially rooted in the 
need to better describe the function of ITK. ITK affects the production DAG 
and IP3 in equimolar amounts (Andreotti et al., 2010; Smith-Garvin et al., 
2009). Within the Tec kinase family, ITK performance in kinase assays is not 
very impressive and activation is more or less dispensable under strong 
stimulation conditions (Andreotti et al., 2010; Joseph et al., 2013). Yet ITK 
activity was proving critical in giving CD8 T cells the ability to optimally tune 
37
graded gene expression, such as IRF4, at 24 hours (Conley et al., 2020). I 
reasoned that close examination of the major signaling pathways directly 
under the influence of ITK, specifically Ca2+/NFAT, NF-κB, and MAPK, may 
not all respond similarly to changes in TCR stimulation or ITK activity. The 
primary goal of my thesis was to link ITK activity and TCR signal strength 
with the regulation of early gene transcription. 
Chapter III: Differential TCR signaling within individual CD8+ T cells 
 This chapter tested the hypothesis that ITK activity specifically tunes 
Ca2+/NFAT signaling. To do this, I optimized a flow cytometry assay to 
measure transcription factor translocation in single, peptide stimulated cells 
with flow cytometry. I then measured NFAT, NF-κB, and pErk1/2 activation 
after stimulation with APCs presenting variable affinity peptides or during 
treatment with ITK inhibitor PRN-694. The key observation was that ITK 
regulates the digital activation kinetics of NFAT, but NF-κB signal intensity  
was very sensitive to PRN-694 treatment. 
Chapter IV: ITK control of early gene transcription in activating 
CD8+ T cells 
 Developed alongside experiments in Chapter III, the experiments in 
this chapter tested the hypothesis that differential signaling conditions 
produced by weakened ITK activity would have immediate effects on graded 
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gene expression. To do this, I stimulated OT-I cells with peptide antigen with 
or without PRN-694, and performed RNA-seq and ATAC-seq. Transcriptional 
differences that I observed were then validated for differences in protein 
expression in single cells by flow cytometry. I also used an NF-κB inhibitor to 
test the extent that NF-κB signaling regulated graded early gene expression. 
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Chapter II: Methods 
Mice 
Mice were bred and housed in a specific pathogen-free facility at the 
University of Massachusetts Medical School (Worcester, MA) in accordance 
with Institutional Animal Care and Use Committee guidelines. OT-I 
transgenic Rag1-/- mice (B6.129S7-Rag1tm1Mom Tg(TcraTcrb)1100Mjb N9+N1) 
and C57BL/6 wildtype mice were purchased from Taconic Biosciences. 
CD45.1+ (B6.SJL-PtprcaPep3b/BoyJ) mice were purchased from The Jackson 
Laboratory. Unless otherwise noted, experimental cohorts consisted of age 
and sex-matched littermates aged 6-12 weeks. 
Stimulation of CD8+ T cells 
Freshly harvested OT-I Rag1-/- mouse splenocytes were pooled, RBC lysed, 
and enriched for CD8+ cells with an EasySep™ negatively selective magnetic 
isolation kit (STEMCELL Technologies). OT-I cells prepared for use in nuclei 
isolation experiments were then treated with CellTrace™ Violet reactive dye 
(Invitrogen) for 20 minutes to fluorescently label cells (including nuclei). OT-I 
cells were cultured at 2 x 105 cells per well (unless otherwise noted) and 
incubated with or without 50 nM (or otherwise noted) ITK/RLK inhibitor 
PRN-694 (Principia Biopharma) for 30 minutes 37˚C. In some experiments, 
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OT-I cells were incubated with or without IKK inhibitor IKK-16 (Sigma) or 
MEK inhibitor PD325901 (Tocris Bioscience). For antigen-presenting cells, 
RBC-lysed splenocytes harvested from wildtype mice were cultured at 4 x 105 
per well and incubated with indicated concentrations of OVA “N4” peptide 
(SIINFEKL), altered OVA “T4” peptide (SIITFEKL), or altered OVA “G4” peptide 
(SIITFEKL) (21st Century Biochemicals) for 60 minutes at 37˚C. OT-I cells and 
peptide loaded splenocytes were then combined and incubated at 37˚C for 
indicated stimulation times. For cell preparations used for molecular analyses 
(e.g. RNA-seq and ATAC-seq analyses), splenocytes from CD45.1+ wildtype 
mice were used as peptide presenting cells for easy exclusion from CD45.2+ 
OT-I cells via cell sorting. 
Nuclei isolation 
To measure translocation of nuclear proteins, I isolated cell nuclei after 
stimulation for fixation and subsequent flow cytometry analysis. To do this, I 
utilized a sucrose buffer-based protocol that I and others have published 
(Gallagher et al., 2018; Podtschaske et al., 2007). To summarize, stimulated 
cells were pelleted and washed with 200 µL of ice cold “Buffer A” containing 
320 mM sucrose, 10 mM HEPES (Life Technologies), 8 mM MgCl2, 13 EDTA-
free cOmplete Protease Inhibitor (Roche), and 0.1% (v/v) Triton X-100 
(Sigma-Aldrich). After 15 min on ice, the plate was spun at 2000 x g and 4°C 
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for 10 min. This was followed by 2X 200 µL washes with “Buffer B” (Buffer A 
without Triton X-100) at 2000 x g and 4°C. 
Confocal imaging  
For imaging, whole cells and nuclei were fixed and stained with fluorescent 
Abs similarly to flow cytometry preparation. After staining, pellets were 
resuspended in ~10 µl of PBS, pipetted onto glass slides, and mounted with 
ProLong Gold Antifade Reagent with DAPI (#8961; Cell Signaling Technology). 
Images were collected on a Leica SP5 confocal microscope with a 63X oil 
objective using Leica LAS AF software. Images were processed and merged 
using ImageJ software (National Institutes of Health). 
Antibodies and flow cytometry 
Stimulated cells and isolated cell nuclei were fixed and permeabilized with 
the Foxp3 / Transcription Factor Staining Buffer Set (eBioscience), except 
cells used for anti-p-Erk1/2 analysis, which were fixed with 4% 
paraformaldehyde (Electron Microscopy Services) and permeabilized with 
90% ice-cold methanol (FisherSci). Fluorescently labeled flow cytometry 
antibodies against IRF4 (3E4), CD69 (H1.2F3), and Egr2 (erongr2) were 
purchased from eBioscience. Antibodies against CD8a (53-6.7), CD8b (53-5.8), 
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CD25 (3C7), CD90.2 (53-2.1), pErk1/2 (4B11B69) were purchased from 
BioLegend. Antibodies against NFAT1 (D43B1), NF-κB p65 (D14E12), c-Fos 
(9F6), and c-Myc (D84C12) were purchased from Cell Signaling Technology. 
Anti-CD45.1 (A20) was purchased from BD Pharmingen. PE-conjugated 
F(ab')2-goat anti-rabbit IgG (H+L) cross-adsorbed secondary antibody was 
purchased from Invitrogen. 
Cell Sorting 
Samples of stimulated CD45.2+ OT-I cells and CD45.1+ wildtype splenocytes 
mixtures were stained with CD8a and CD45.2 antibodies and 7-AAD and OT-I 
cells were sorted (BD FACSAria) into 100% FBS and pelleted. 
RNA-seq library preparation 
Total RNA from ~300,000 OT-I cells per sample was collected with the 
RNeasy micro kit (Qiagen) with a 15-minute on-column DNase digestion 
(Qiagen) to remove genomic DNA. Total RNA quality and quantity was 
determined with fragment analysis (University of Massachusetts Medical 
School Molecular Biology Core Lab) and Qubit Fluorometer (Invitrogen) 
analysis. cDNA libraries were generated following a modified paired-end 
SMART-seq protocol (Kriegsman et al., 2019; Ramsköld et al., 2012). Briefly, at 
least 20 ng of input RNA was used for reverse transcription with 
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SMARTscribe reverse transcriptase (Clontech). Whole transcriptome 
amplification (WTA) was performed with Advantage 2 polymerase (Takara 
Bio). WTA reactions were monitored with qPCR to determine optimal cycle 
number. WTA libraries were then sized-selected with AMPure XP DNA SPRI 
beads (Beckman Coulter), tagmented with Tn5 transposases (Illumina 
Nextera XT), barcoded, and amplified with cycle number determined via 
qPCR monitoring. Final libraries were further size-selected with SPRI beads 
to an average size of 300-500 bp and quality was assessed with fragment 
analysis and Qubit analysis. Libraries were pooled and sequenced on a 
NextSeq 500 sequencer (Illumina). 
Processing and analysis of RNA-seq reads 
Adapter sequences were trimmed from quality raw sequencing reads with 
Trimmomatic-0.38 (Bolger et al., 2014) and then aligned to mouse ribosomal 
RNA with Bowtie2 v2.3.2 (Langmead and Salzberg, 2012). Unaligned reads 
were retained, and gene expression was estimated (transcripts per million 
and expected counts) with RSEM v1.2.29 (Li and Dewey, 2011) configured to 
align to a mm10 RefSeq transcriptome with Bowtie2 v2.3.2. Samples were 
filtered to retain expressed genes (expected counts > 200) and batch effects 
between replicates were corrected with limma v3.42.2 (Ritchie et al., 2015). 
Differential expression analysis was performed with DESeq2 v1.26.0 (Love et 
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al., 2014) to identify induced genes (stimulated conditions vs. unstimulated 
controls) or condition-specific changes in expression (untreated vs. PRN-694 
or N4 vs T4 OVA peptides). Hierarchical clustering and k-means clustering of 
differentially expressed genes was performed within R v3.5. Heatmap 
visualizations of gene clusters were drawn with ComplexHeatmap (Gu et al.). 
Gene ontology 
I utilized the R package msigdbr v7.0.1 to compare clusters of differentially 
expressed genes with the Molecular Signatures Database (MSigDB) Hallmark 
(H) and Immunologic (C7) gene sets (Godec et al., 2016; Liberzon et al., 2015; 
Subramanian et al., 2005). The top five terms with FDR <0.05 were displayed 
in the Results. 
ATAC-seq library preparation 
Precisely 50,000 stimulated OT-I T cells were FACS sorted at the same time 
as RNA-seq samples and pelleted in 100% FBS. ATAC-seq libraries were 
generated similarly as described in Buenrostro et al., 2013 (Buenrostro et al., 
2013). Briefly, cell nuclei were isolated and transposed with 8 µL Tn5 (Illumina 
Nextera) at 37˚C for 60 minutes. DNA fragments were isolated with a Clean 
and Concentrator Kit (Zymo) and then Illumina barcoded and amplified with 
NEBNext High-Fidelity 2x PCR Master Mix (New England Biolabs). A portion 
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of the reaction was performed as a separate qPCR reaction to determine 
ideal cycle number. Samples were then size selected with SPRI beads to 
include fragments up to 450 bp, ensuring to maintain small (<200 bp), 
nucleosome-free fragments. Quality of final ATAC-seq libraries was assessed 
with fragment analysis and Qubit analysis. Libraries were then pooled and 
sequenced on an Illumina NextSeq 500. 
Alignment and processing of ATAC-seq reads 
Adapter sequences were trimmed from raw sequencing reads with Cutadapt 
v1.3 (Martin, 2011) and then aligned to the mouse genome (mm10) with 
Bowtie2 v2.1.0 with the parameter -X 2000. PCR duplicates were removed 
with Picard’s markDuplicates v2.17.8 and aligned reads were sorted and 
filtered with SAMtools v1.4.1 (Li et al., 2009). For visualization of fragment 
coverage TDFs were generated with IGVTools v2.3.31 (Robinson et al., 2011; 
Thorvaldsdóttir et al., 2013). 
Peak calling 
Aligned ATAC-seq reads were trimmed to 29 bases closest to the Tn5 cut site 
with bedtools v2.26.0 (Quinlan and Hall, 2010) and then peaks were called 
with MACS2 v2.1.1 (Zhang et al., 2008) using parameters --bw 29 --nomodel 
-q 0.0001. Summits of called peaks across all samples were merged and 
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“slopped” ±100bp to create a master peak reference file using bedtools 
v2.26.0. Peaks were annotated with names of closest genes using a mouse 
OT-I TSS BED file and bedtools v2.26.0 (closest -D ref -t all). Peaks with 
summits within 500 bp from TSSs were labeled “promoter” peaks and 
summits further than 500bp were labeled “enhancer” peaks. Peak coverage 
for each ATAC-seq sample was calculated using bedtools v2.26.0 (intersect; 
coverage). 
Differential Peak Analysis 
Calculated peak coverage values for two ATAC-seq replicate experiments 
were used as input for differential analysis using DESeq2 v1.26.0. All 
differential peaks (compared to unstimulated controls) were clustered using 
either hierarchical or k-means clustering methods within R. Heatmaps were 
generated with ComplexHeatmap. 
Motif enrichment. 
Each cluster of annotated differentially accessible peak regions was tested 
for de novo motif enrichment using HOMER v4.10.3 (findMotifsGenome.pl 
-size 200) with background comprised of peak regions found in all other 
clusters (Heinz et al., 2010). 
47
Genomic Visualizations 
Genomic tracks were created by plotting BigWig files with help of Gviz 
(Hahne and Ivanek, 2016) PMA and ionomycin ATAC-seq tracks and NF-κB 
ChIP-seq tracks were extracted from publicly available sources (Mognol et 
al., 2017; Oh et al., 2017). 
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Chapter III: Differential TCR signaling within individual CD8+ T cells 
Differential TCR signaling within 
individual CD8+ T cells 
Preface 
This chapter encompasses the principal findings presented in the following 
publications:
1. Gallagher MP, Conley JM, Berg LJ (2018) Peptide Antigen Concentration 
Modulates Digital NFAT1 Activation in Primary Mouse Naive CD8+ T 
Cells as Measured by Flow Cytometry of Isolated Cell Nuclei. 
Immunohorizons. 
2. Conley JM, Gallagher MP, Rao A, Berg LJ (2020) Activation of the Tec 
Kinase ITK Controls Graded IRF4 Expression in Response to Variations 
in TCR Signal Strength. J Immunol. 
As well as experiments in the prepared manuscript:
3. Gallagher MP, Conley JM, Vangala P, Garber M, Reboldi A, Berg LJ. 
(2020) The Tec kinase ITK differentially optimizes NFAT, NF-κB, and 
MAPK signaling during early T cell activation to regulate graded gene 
induction. bioRxiv doi: 10.1101/2020.11.12.380725
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Summary 
 In this chapter I present experiments that measured NFAT, NF-κB, and 
Erk1/2 responses in single CD8+ T cells. In an attempt to connect observed 
graded gene expression induced at 24 in response to graded TCR stimuli, I 
hypothesized that Ca2+/NFAT signaling was differentially tunable by signal 
strength and ITK activity. Single cell flow cytometry data measuring 
individual pathway activation did not support this hypothesis. Instead, the 
results suggest naive CD8+ T cells largely “switch on” downstream signaling 
pathways digitally, as measured with NFAT1 translocation and pErk1/2 
activation. The rate of digital activation is dependent on the strength of 
stimulus, with weaker TCR inputs or ITK inhibition reducing the frequency 
that single T cells would active within a clonal pool. However NF-κB was an 
exception to these observations, requiring strong TCR stimulation to elicit 
robust activation, and was specifically sensitive to inhibition of ITK activity. 
These results imply separate downstream signal pathways activate 
independently from one another at different thresholds of TCR stimulation. 
Additionally they highlight a supportive role for ITK: amplifying the strength 
of TCR signaling within T cells to robustly activate all divergent pathways 
under its influence. 
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Introduction 
 When I began in the Berg Lab, preliminary data (now published) had 
demonstrated that TCR signal strength carefully tuned the peak amount of 
IRF4 expressed in activated T cells after 24 hours (Conley et al., 2020). Under 
our in vivo testing conditions, IRF4 induction had a temporal window of peak 
expression; weaker-stimulated cells did not accumulate additional IRF4 
protein at later time points. Regulating the concentration of specific OVA 
peptide variants presented on APC cell surfaces could modulate the 
amplitude of IRF4 expression. These experiments demonstrated the quality 
of early TCR signaling had considerable effects in regulating the effector 
programming within newly-activated cells. 
 At the same time, another series of experiments utilizing OT-I Rag1-/- 
Itk-/- mice was teaching us how ITK activity also tuned IRF4 expression. 
However, the role of ITK activity was nuanced, as it was more beneficial 
during moderate or weaker signaling conditions. When stimulated with 
moderate or low-affinity altered OVA peptides (T4 or G4), activated OT-I 
Itk-/- cells (based on digital CD69 expression) accumulated notably less IRF4 
protein than WT OT-I cells (Fig. 3.1A-B). OT-I Itk-/- cells stimulated with 
strong, native (N4) OVA peptide had a lessened, but consistent defect in IRF4 
expression. Treating WT OT-I cells with different doses an ITK inhibitor 
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modulated IRF4 expression gradually within T cells that were digitally CD69 
positive (not shown). Increasing the dose of a peptide presented to Itk-/- T 
cells could not fully recover the defect in IRF4 expression compared to WT 
(Fig. 3.1B). Similarly, high concentration of weaker T4 or G4 peptides could 
not reach the same maximum IRF4 expression achieved with high affinity N4 




Figure 3.1. Regulation of graded IRF4 expression in CD8+ T cells. 
(A and B) ITK inhibition reduces maximum IRF4 expression in CD8+ T cells in a graded manner. OT-I 
WT (Itk+/+) or OT-I Itk-/- (Itk-/-) T cells were stimulated with each peptide for 24 h at multiple doses. 
Percentage of CD69+ (A) and IRF4 MFI (B) are plotted for each peptide concentration. (C) Calcium 
signaling drives graded IRF4 expression in CD8+ T cells. OT-I T cells were treated with varying doses of 
PMA or ionomycin for 24 h, and cells were stained for intracellular IRF4. Representative histograms of 
IRF4 staining are shown.
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recover deficiency in CD69 expression due to lack of ITK or stimulation with 
weak affinity peptide (Fig. 3.1A). From these experiments my colleagues 
concluded that TCR input and ITK activity modulated graded gene 
expression within cells that switched on digitally. Signal transduction beyond 
proximal TCR triggering required further examination to better understand 
the mechanism that achieves these expression patterns.
The preliminary results above supported previously developed 
concepts that ITK activity does not steadily amplify all TCR signals, but 
rather its contribution is more beneficial during weaker signaling conditions 
(Andreotti et al., 2010). It was unclear whether the additive signal 
contribution of ITK activity is limited or ITK activity is biochemically 
regulated, or both. Further, gene expression in activating CD8+ T cells 
displayed differential sensitivity to ITK activity (and broadly, signal strength), 
as demonstrated by the disparate patterns in expression when comparing 
genes like CD69 and IRF4. 
There is evidence that connects TCR ligation with digital T cell 
activation. Increasing the dose of peptide reliably increases the proportion of 
responding T cells as measured by IL-2, IFN-ɣ cytokine, or CD69 and Myc 
expression (Altan-Bonnet and Germain, 2005; Conley et al., 2016; Das et al., 
2009; Huang et al., 2013; Preston et al., 2015). However, the amount of protein 
measured within single cells is similar. I observed CD69 reliably switched on 
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digitally in individual cells, but IRF4 expression was malleable and dependent 
on the strength of signal or ITK activity (Fig. 3.1A-B). 
The question of how digitally switched T cells regulate graded gene 
expression remained unanswered. Does the complex orchestration of diverse 
intermediate downstream signaling pathways reflect both the digital 
switching behavior of the proximal TCR and analog tuning capability? Does 
ITK play a role in such differential patterns of signaling?  
 Because the primary substrate for ITK is PLC-ɣ1, I focused my efforts 
on characterizing major signaling pathways downstream of PLC-ɣ1 
simultaneously in activating cells. This included pathways terminating with 
NFAT (Ca2+) and NF-κB transcription factors, and the Erk/MAPK cascade. 
Digital signaling in individual cells has been best characterized by digital 
phosphorylation of Erk, a phenomenon achieved through both positive and 
negative feedback mechanisms (Altan-Bonnet and Germain, 2005; Das et al., 
2009). Digital activation of both the Ca2+ pathway and the NF-κB pathway 
have also been described under some conditions (Dura et al., 2016; Kingeter 
et al., 2010; Podtschaske et al., 2007). 
I posited that separate pathways do not always respond similarly to a 
TCR stimulus. For example, what is the relative amount of Ca2+ activation 
within single cells during TCR conditions that digitally trigger pErk? 
Pathways may require different thresholds of upstream TCR stimulation or 
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ITK activity, creating conditions that could impart imbalance in activation of 
NFAT, NF-κB, and MAPK. I reasoned factors not acting in concert may have 
implications for differential regulation of activation-associated transcription, 
which I had already observed. I believed close examination of simultaneous 
pathway activation would better link proximal TCR signaling mechanics with 
graded gene expression.
Preliminary data (now published) using altered OVA peptide-
stimulated OT-I cells hinted that graded IRF4 regulation may be more 
dependent on Ca2+ arm of PLC-ɣ1 dependent signaling (Conley et al., 2020). 
Titrated amounts of ionomycin, which increases intracellular Ca2+,  induced 
precise, graded IRF4 expression (Fig. 3.1C). PMA addition however, which 
mimics DAG, induced a small amount of IRF4 in a digital manner. This 
information, combined with the previous knowledge that Itk-/- T cells 
display significant defects in Ca2+ signaling, I hypothesized that the Ca2+ 
(NFAT) pathway would be more incrementally sensitive to TCR signal 
strength and ITK activity, while other pathways (e.g. NF-κB, MAPK) 
digitally respond to a threshold amount of TCR signaling (Fig. 3.2)(Atherly 
et al., 2006; Donnadieu et al., 2001; Liu et al., 1998; Miller et al., 2004; 
Schaeffer et al., 1999). I sought to measure each pathway simultaneously in 
OT-I cells to determine their relative activation. 
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 I chose to utilize a TCR transgenic mouse model that would allow us to 
stimulate and analyze pools of naive, clonal CD8+ T cells. The well-described 
OT-I TCR transgenic model offered CD8+ cells that elicited robust TCR 
mediated T cell activation when stimulated with native ovalbumin peptide, 
but also had available a spectrum of altered OVA peptides of variable koff 
values and with varied measured functional avidities (Hogquist et al., 1994; 
Zehn et al., 2009). Splenic T cells isolated from OT-I Rag1-/- mice cannot 
FIGURE 2 | ITK acts as a rheostat for the TCR signaling pathway. While the expression of genes like CD69 and IL-2 is not directly proportional to the signaling 
input at the TCR, other genes like IRF4 have a graded response where expression continues to increase with higher af!nity TCR stimulation. High-af!nity antigens 
increase the duration of TCR binding, increasing the stability of activated Lck and Zap70, which ampli!es downstream signaling by creating a larger pool of activated 
LAT signaling complexes. This creates a larger pool of activated ITK, represented here for simpli!cation without the other signaling components in the pathway. We 
propose that the calcium signaling pathway is uniquely sensitive to ITK and can provide a mechanism for graded IRF4 expression.
February 2016 | Volume 7 | Article 764
Conley et al. Digital and Graded TCR Signaling
Frontiers in Immunology | www.frontiersin.org
ablated response. While the MAPK pathway is only modestly 
impaired in Itk-de!cient T cells, the magnitude of calcium "ux 
is greatly reduced in response to antigen (12). #is reduction in 
signaling correlates with a reduction in CD8 clonal expansion 
in response to infection (49). A key set of experiments directly 
compared kinase dead mutants of Lck and ITK in activated T cells 
(50). While both mutants inhibited calcium "ux in the T cells, the 
kinases had very di$erent e$ects on the whole population. #e 
Lck mutants ablated calcium signaling in a proportion of the T 
cells, while ITK mutants dampened the calcium response of each 
cell in the entire population. #is suggests a digital regulation of 
calcium signaling through Lck and an analog regulation through 
ITK. We propose that ITK and the calcium signaling pathway 
are critical for maintaining the analog nature of this TCR output 
(Figure!2).
GRADED TCR SIGNALING AND CD8 
T!CELL FUNCTION
CD8 T cell development and function have been studied using 
the OT-I transgenic mouse model. #e OT-I TCR recognizes 
the SIINFEKL peptide (OVA), an antigen derived from chicken 
ovalbumin (51). #ese OT-I T cells are MHC class I restricted, 
creating a large population of naive CD8 T cells that recognize 
the Ova antigen. #e OT-I model provides an excellent system to 
study TCR signal strength because of the exquisitely high-a%nity 
OVA peptide ligand. APLs with single amino acid substitutions 
greatly reduce TCR-binding a%nity while maintaining equivalent 
MHC-binding capacity. Scientists have also engineered a variety 
of pathogens to express these APLs, providing excellent infection 
models to study TCR signal strength in!vivo. In the context of CD8 
T cell development in the thymus, graded TCR signal strength 
drives the balance between positive and negative selection, a 
process that can directly impact autoimmune disease (52–54).
A series of studies have looked at CD8 T cell activation in!vivo 
in response to infection and have teased apart contributions 
between antigen interactions and environmental in"amma-
tory signals. While T cell expansion was directly proportional 
to antigen avidity, cytolytic function was more dependent on 
in"ammatory signals (55, 56). Using peptide-pulsed dendritic 
cells with or without Listeria monocytogenes infection, granzyme 
B and IFN-! production were only seen in the context of infec-
tion. However, IL-2 and the chemokine receptor CCR7 were 
regulated in the absence of in"ammation, and their expression 
was directly proportional to the avidity of the antigen. #e high-
a%nity IL-2 receptor (CD25) was driven by both signals with its 
expression proportional to both dose and a%nity of the stimulus 
(55, 57). #ese Listeria experiments show that certain aspects 
Figure 3.2. Hypothesis: ITK activity tunes graded gene expression through differential 
activation of Ca2+/NFAT sig aling. 
While the expre sio of genes like CD69 is not directly proportional to the signaling input at the TCR, 
other genes like IRF4 have a graded response where expression continues to increase with higher 
affinity TCR stimulation. High-affinity antigens increase the duration of TCR binding, increasing the 
s ability of activated Lck and Zap70, which amplifies downstream signaling by creating a larger pool 
of activated LAT signaling complexes. This creates a larger pool of activated ITK, represented here for 
simplification without the other signaling components in the pathway. I hypothesized that the 
calcium signaling pathway is uniquely sensitive to ITK and can provide a mechanism for graded IRF4 
expression. Adapted from Conley et al., 2016.
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rearrange an endogenous receptor and only express an OT-I TCR. Thus all 
isolated CD8+ T cells were clonal and had not experienced antigen (all naive), 
which I could confirm by surface staining for activation markers such as 
CD44.  
A tool that proved indispensable for my analyses was PRN-694, a 
covalent inhibitor of both ITK and RLK (Zhong et al., 2015). Naive CD8+ T cells 
express both ITK and RLK, but ITK predominates (Andreotti et al., 2010; Berg 
et al., 2005; Zhong et al., 2015). Splenic T cells from germ line Itk-/- mice 
develop in the thymus without the benefit of ITK, thus experience different 
selection conditions. Mature ‘naive’ Itk-/- cells present a ‘memory like’ 
phenotype in the periphery and may exhibit compensatory transcriptional 
programming, resulting in different expression of other Tec kinases (e.g. 
RLK). This makes comparisons between peripheral WT cells and Itk-/- cells 
less than ideal. Treating mature naive WT OT-I cells with PRN-694 allowed us 




Nuclei flow cytometry assay optimization 
 To observe activation of separate TCR signaling pathways in individual 
cells, I optimized a flow cytometry assay that measures transcription factor 
protein content in ex vivo mouse naive T cell nuclei. Factors such as NFAT 
and NF-κB are normally sequestered in the cytoplasm and translocate to the 
nucleus following TCR engagement (Gaud et al., 2018; Smith-Garvin et al., 
2009; Trebak and Kinet, 2019). A colleague in the department initially 
recommended nuclear fractionalization followed by flow cytometry analysis, 
with which they were familiar in applications for mouse dendritic cells. 
Consulting already developed procedures for immune cell nuclear 
fractionalization, I first tested gradient separation methods (Poglitsch et al., 
2011). This utilized iodixanol, an osmotically neutral density gradient medium, 
which has the benefit for carefully tuning lysis conditions to separate live 
organelles. In brief, live stimulated cells were centrifuged through gradient 
layers of iodixanol, including one detergent layer to lyse the plasma 
membrane. Nuclei were extracted from the middle layers, then washed and 
stained for flow cytometry (Fig. 3.3A).  
 The gradient-based procedure generated clean OT-I nuclei free of 
cytoplasmic tubulin proteins, mitochondrial COX IV membrane proteins, but 
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contained histones and stained positive for DNA intercalating propidium 
iodide (Fig. 3.3B). One drawback to this procedure was poor throughput. Low 
nuclei yield and the unwieldy layering of one gradient tube per sample 
Figure 3.3. Overview of nuclei isolation techniques for flow cytometry analysis. 
(A) Diagram of iodixanol gradient nuclei isolation preparation. (B) Control staining for nuclei isolated 
via iodixanol gradient. Whole cells are depicted in dark blue and nuclei are green. (C) Overview of 
sucrose buffer based nuclei isolation procedure. (D) Representative forward scatter (FSC) and side 
scatter (SSC) plot of OT-I nuclei isolated and fixed in sucrose buffer compared with OT-I whole cells. 
(E) Flow cytometry histograms comparing nuclei versus whole cells stained with indicated Abs or 
propidium iodide (P.I.). (F) Confocal images displaying NFAT1 localization in isolated OT-I nuclei 
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limited the number of experimental conditions that could be simultaneously 
tested.  
 I turned to a sucrose solution-based nuclei isolation technique that 
had the advantage of being performed in a 96-well plate. A similar procedure 
had also been previously utilized for mouse T cell nuclei flow cytometry 
(Podtschaske et al., 2007). To perform this method, stimulated cells or cell 
cultures were centrifuged and briefly washed “on plate” with sucrose 
detergent buffers for lysis. Nuclei were fixed and stained for flow cytometry 
(Fig. 3.3C). The sucrose-based assay produced viable nuclei for analysis 
similar to the density gradient procedure, as evident by smaller forward and 
side scatter size, β-tubulin staining and binding of propidium iodide, but was 
more scalable in practice (Fig. 3.3D-E). Validation with confocal imaging 
confirmed NFAT1 was sequestered to the cytoplasm in naive cells, but 30 
minutes after adding the Ca2+ ionophore ionomycin NFAT1 localized nearly 
entirely in nuclei (Fig. 3.3F). Importantly, nuclei isolated from unstimulated 
OT-I cells lacked NFAT1 signal. 
 In order to measure more physiological NFAT, NF-κB and Erk 
responses and to compare with patterns of graded IRF4 expression, I wanted 
to stimulate naive OT-I cells with APCs presenting peptide antigens. To 
analyze isolated OT-I nuclei from mixed cultures, I stained the pool of naive 
OT-I cells with cell proliferation dye CellTrace Violet prior to co-culture with 
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peptide-loaded APCs (Fig. 3.4A-B). Because CellTrace is a succinimidyl ester 
dye that binds all free amines, CD8+ T cell nuclei retained fluorescence after 
isolation and could be distinguishable from unlabeled APC nuclei during flow 
cytometry analysis (Fig. 3.4C) (Filby et al., 2015). This allowed close 
examination of transcription factor localization specifically within OT-I 
Figure 3.4. Nuclei isolation from APC and T cell co-cultures. 
(A) Overview of coculture experimental setup. OT-I splenocytes were enriched for CD8+ T cells by 
negative selection and labeled with CellTrace Violet dye. Wild-type splenocytes were harvested 
separately and pulsed with OVA peptide. Labeled OT-I cells were mixed (~1:3) with bulk splenocytes 
for desired time. (B) Summary of the nuclei isolation protocol. After coculture stimulation, mixed OT-I 
and wild-type cells were lysed in a sucrose and detergent buffer, centrifuged, and washed 2X prior to 
fixation with 4% paraformaldehyde. (C) Flow cytometry gating strategy to identify OT-I nuclei after 
coculture stimulation. Fixed nuclei were stained with a fluorescent Ab against β-tubulin prior to 
analysis. OT-I nuclei were identified by gating on singlets by side scatter height (SSC-H) and SSC width 
(SSC-W) and on β-tubulinlo, CellTrace Violethi events. (D) Flow cytometry comparison of isolated OT-I 
nuclei or whole cells (pre-labeled with CellTrace Violet) after 30 min of coculture with 1nM OVA 































nuclei immediately after stimulation by splenocytes presenting cognate 
peptide (Fig. 3.4D). 
TCR regulation of digital NFAT activation in single T cells. 
 To test the hypothesis that TCR signal strength could tune Ca2+/NFAT 
signaling in CD8+ T cells, I used flow cytometry to characterize the behavior 
of NFAT1 localization in OT-I nuclei during variable peptide antigen 
stimulation conditions. Time course experiments revealed native OVA 
peptide stimulation induced digital NFAT1 translocation that persisted for at 
Figure 3.5. Digital NFAT1 translocation in OVA peptide stimulated naive OT-I cells.  
(A) Line plots depicting compiled time course results from two experiments measuring NFAT1 
localization in OT-I nuclei after coculture with bulk splenocytes pulsed with the indicated dose of OVA 
peptide. (B) Representative flow cytometry histograms of NFAT1-positive OT-I nuclei after 45 min of 
coculture with bulk splenocytes pulsed with indicated dose of OVA peptide. (C) Representative flow 
cytometry histograms displaying a time course of NFAT1 staining in OT-I nuclei after coculture with 























































least 4 hours (Fig. 3.5A-B). Decreasing the concentration of OVA peptide 
presented to OT-I cells reduced both the maximum percentage of NFAT1 
responding cells and the rapidity of converting a NFAT1 positive population 
(Fig. 3.5A,C). Importantly, these experiments revealed weaker TCR 
stimulation did not produce appreciable differences in fluorescence intensity 
of NFAT1 within individual cells. This indicated NFAT1 activation was 
probabilistic in nature within single cells, where TCR stimulus controlled how 
likely a cell would cross a signaling threshold to digitally switch on NFAT1. My 
initial observations of digital NFAT1 pathway activation mirrored digital 
Figure 3.6. NFAT1 export dynamics in OT-I nuclei. 
(A) Line plots depicting median fluorescence intensity (m.f.i.) of NFAT1 in isolated OT-I nuclei 
stimulated similarly to Fig. 3.5. After 30 min of stimulation with OVA peptide, either 5 mM EDTA, 
5 mM EGTA, or 100 nM FK506 was added to culture media where indicated. Samples were 
collected 0, 15, 30, 60, and 90 min after adding inhibitors. (B) Representative histograms of 
three experiments performed showing EGTA effects on NFAT1 exit from OT-I nuclei. OT-I cells 
were cocultured with bulk splenocytes pulsed with 100 pM of OVA peptide. After stimulation for 
30 min to allow for nuclear translocation of NFAT1, 5 mM EGTA was added to culture, and 




























behavior of proximal TCR triggering, and did not support the notion that Ca2+ 
(NFAT) could be finely tuned in a graded manner (Altan-Bonnet and Germain, 
2005; Das et al., 2009).  
 To test whether sustained NFAT1 nuclear localization was due to 
continued, productive TCR signals or a prolonged effect after the initial 
contact, cell contacts were disrupted with chelating agents ethylene glycol-
bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) or 
ethylenediaminetetraacetic acid (EDTA), or a calcineurin inhibitor FK506. 
When added 30 minutes after stimulation with N4 peptide, which would 
allow for maximum NFAT1 import, all treatment conditions exhibited a 
similar pattern in retreat of nuclear NFAT1 signal (Fig. 3.6A). While strong N4 
OVA peptide stimulation imported NFAT1 in rapidly in digitally switched cells, 
the NFAT1 export rate due to each agent appeared to be consistently slower, 
taking about 60 minutes to return to baseline. NFAT1 export also does not 
appear to be regulated digitally, as T cells treated with EGTA have 
intermediate intensity of NFAT1 fluorescence (Fig. 3.6B). Observations of 
rapid NFAT import and slower export has been described previously 
(Marangoni et al., 2013). It was likely that continued productive TCR signals 
maintained persistent Ca2+ flux and NFAT1 nuclear localization (DISC). These 
experiments also do not support the possibility that stable proportions of 
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NFAT1 responders within a stimulated OT-I population represent an 
equilibrium of NFAT1 import and export (shuttling). 
 To characterize the behavior of NFAT activation during weaker affinity 
TCR stimulation, naive OT-I cells were stimulated with splenocytes loaded 
with SIITFEKL (T4) altered OVA peptide (Zehn et al., 2009). T4 peptide 
stimulated cells also displayed digital NFAT1 activation, as a positive fraction 
of cells emerged over time in a bimodal distribution (Fig. 3.7A). Varying 
concentrations of either N4 (native) OVA peptide or T4 and weaker SIIGFEKL 
(G4) altered peptides demonstrated that higher concentrations of weaker 
peptides could not achieve the same maximum percentage of NFAT1 
responders that was observed after native N4 peptide stimulation (Fig. 3.7B). 
This pattern looked similar to peptide affinity control of maximum IRF4 
expression at 24 hours; higher doses of weaker peptides simply cannot 
achieve N4 equivalent maximum IRF4 expression (Fig. 3.1B). One difference in 
NFAT1 activation due to peptide affinity was a delay in the onset of the first 
NFAT1 positive cells. Higher dose of T4 peptide could achieve a similar 
maximum percentage of NFAT1 responding cells as a lower dose of high 
affinity N4 peptide (e.g. 100 nM T4 peptide and 1 nM N4 both elicit ~80% 
NFAT1 responders) (Fig. 3.7C). However, NFAT1 positive nuclei were not 
detected until 30 minutes after stimulation and did not reach maximum until 
60 minutes. N4 stimulated cells however, began digitally activating NFAT1 as 
65
early as five minutes and the peak response was before 30 minutes. Thus, 
conditions exist where a weaker affinity peptides can elicit a similar 
percentage of NFAT1 responding OT-I cells as high affinity peptide, but over a 
longer duration of activation. Peptide affinity and concentration are 
therefore not precisely interchangeable. 
 To test whether ITK activity tunes Ca2+/NFAT activation within single 
cells, I stimulated OT-I T cells with splenocytes presenting T4 peptide, with 
and without ITK/RLK inhibitor PRN-694. ITK-inhibited T cells exhibited 
digital activation of NFAT1, but generated a smaller fraction of responders 
(Fig. 3.7D-E). This reduction of NFAT1 responders was consistent across all 
doses of T4 peptide tested (Fig. 3.7E). Constant digital NFAT1 behavior 
indicated ITK inhibition did not dampen the intensity of NFAT1 activation 
within single T cells, but instead regulated the threshold of activation, not 
supporting my initial hypothesis. Having a better understanding of NFAT 
signaling behavior in response to peptide dose, affinity, and ITK activity, I 
next turned to measure relative activation of other pathways downstream of 
PLC-ɣ1. 
Graded NF-κB activation within digitally switched T cells 
 To directly compare other signaling pathways within cells that digitally 
switch on NFAT activation, I also measured simultaneous NF-κB (p65) nuclear 
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Figure 3.7. TCR signal strength and ITK activity drives digital NFAT activation in CD8+ T cells.  
(A) Representative histograms of NFAT1 fluorescence in OT-I nuclei isolated after T cells were 
stimulated with WT splenocytes pulsed with indicated doses of T4 peptide for 30 min. (B) Line plots 
of the percentage of NFAT1+ nuclei after 30 min of stimulation with WT splenocytes pulsed with 
indicated doses of either N4, T4, and G4 altered OVA peptides. (C) Line plots of the percentage of 
NFAT1+ OT-I nuclei over a 60-min time course after cells were stimulated and WT splenocytes pulsed 
with varying doses of either N4 (left, blue) or T4 (right, red) peptides as indicated. (D) Representative 
histograms of NFAT1 fluorescence in OT-I nuclei after cells were stimulated for 30 min with WT 
splenocytes pulsed with 25 nM T4 peptide with or without 50 nM PRN-694 treatment. (E) Line plots of 
the percentage NFAT1+ values are shown for the T4 peptide dose response with and without 50 nM 












































































































localization and phospho-Erk1/2 activation in stimulated OT-I cells. 
Consistent with previous descriptions, Erk reliably activated digitally after 
stimulation with strong native N4 OVA peptide (Fig. 3.8A) (Altan-Bonnet and 
Germain, 2005; Das et al., 2009). Under the same strong signaling conditions, 
NF-κB (p65) translocated markedly in nearly all cells. However, weaker 
stimulation with T4 peptide revealed differences between the activation 
kinetics NFAT, NF-κB and Erk pathways. A T4-stimulated pool of naive OT-I 
cells continued to switch on NFAT1 and pErk1/2 signal in a digital manner, 
albeit at different rates and proportions (Fig. 3.8B). After 15 minutes of 
stimulation, half of the T4-stimulated population was NFAT1+ whereas only 
Erk1/2 signal was still minimal. This pointed to different signaling thresholds 
for digital activation of NFAT and MAPK pathways. NF-κB (p65) translocation 
during T4 stimulation did not occur in a bimodal manner, but gradually 
increased in fluorescence intensity over a period of 120 minutes and 
appeared to be independent of the NFAT1 and pErk1/2 activation state. This 
indicated that NF-κB activation may be tunable to TCR signal strength, even 
within cells that had surpassed stimulation thresholds for digital NFAT and 
Erk activation. 
 Further examination uncovered that the dynamics of p65 translocation 
is relatively limited during TCR stimulation in naive T cells, as it responded 
with increased intensity to alternative modes of activation. PMA and 
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ionomycin mimics the effects of DAG and Ca2+ respectively downstream of 
PLC-ɣ1 phosphorylation. PMA/ionomycin therefore induces activation by 
bypassing any normal signal regulation by the proximal TCR signaling 
machinery. Either N4 peptide stimulation or PMA/ionomycin treatment 
translocated NFAT1 in a similar proportion of OT-I cells and the fluorescence 
intensity appeared similar in either condition; consistent with digital 
signaling behavior (Fig. 3.8C). PMA/ionomycin treatment induced p65 with 
considerably increased fluorescence intensity when compared to N4 
peptide-stimulated nuclei. This intermediate level of p65 activation indicated 
that even ‘strong’, near supraphysiological TCR signaling conditions (≥100nM 
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Figure 3.8. Comparison of NFAT1, NF-κB 
(p65), and p-Erk activation behavior in 
naive OT-I cells. 
(A) Histograms of NFAT1 and NF-κB 
fluorescence in isolated OT-I nuclei or p-
Erk1/2 fluorescence in OT-I cells after 
stimulation with APCs plus 100 nM N4 
peptide stimulation for 1 hour.  
(B) Histograms of NFAT1 and NF-κB 
fluorescence in isolated OT-I nuclei or p-
Erk1/2 fluorescence in OT-I cells after 
stimulation with APCs plus 100 nM T4 
peptide for the indicated times.  
(C) Histograms of NFAT1 and NF-κB (p65) 
fluorescence within OT-I nuclei isolated after 
1-hour stimulation with APCs plus 100 nM 
N4 OVA peptide or PMA (10 ng/mL)/
Ionomycin (1 µM) addition. 
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N4 peptide) incompletely induce p65 in single cells. Thus, T cells that switch 
on digital NFAT1 or Erk1/2 activation have a dynamic range of possible NF-κB 
activation states. 
ITK activity tunes graded NF-κB signaling 
 To assess how ITK regulates simultaneous activation of NFAT, NF-κB, 
and Erk, OT-I cells were peptide-stimulated with or without addition 
PRN-694. I first tested the same range of concentrations of N4 (native), T4, or 
G4, peptides utilized in experiments that characterized IRF4 expression and 
digital NFAT1 translocation (Fig. 3.1A-B, Fig. 3.7B). When ITK was inhibited, 
the fraction of NFAT1 positive nuclei was reduced during all peptide 
stimulation conditions, but least so in cells stimulated with strong N4 peptide 
(Fig. 3.9A). NF-κB (p65) translocation was notably hindered by ITK inhibition 
at all doses and affinities of peptide, including N4 stimulation (Fig. 3.9B). 
These results supported a disparity between simultaneous NFAT1 and NF-κB 
responses within single cells. 
 Time course analysis during stimulation with single doses of either N4 
or T4 peptide showed that NFAT1 and Erk activation patterns continued at 
least 4 hours after initial TCR contact and maintained digital activation 
behavior during PRN-694 treatment (Fig. 3.9C). NFAT1 translocation 
continued to be less sensitive to ITK inhibition during N4 stimulation (Fig. 
70
Figure 3.9. ITK inhibitor PRN-694 selectively dampens NF-κB activation. 
(A-B) Line plots depicting NFAT1 or NF-κB (p65) activation in response to 30 minute stimulation by 
WT splenocytes loaded with indicated doses of N4, T4, or G4 peptide, with or without treatment 
with 50 nM PRN-694. (C) Line plots depicting either NFAT1 or NF-κB fluorescence within OT-I nuclei 
or p-Erk fluorescence in OT-I cells over 2-hour stimulation with APCs plus 100 nM of indicated 
peptide with or without 50 nM PRN-694. Histograms to the right represent nuclear or whole cell 
fluorescence patterns after 60 minutes of stimulation. (D) Histograms depicting NF-κB (p65) 
fluorescence within NFAT1+ nuclei after 1-hour stimulation in conditions as in C. (E) Line plots of 
change in normalized NFAT1 MFI (%) or normalized NF-κB (p65) MFI (%) within NFAT1+ OT-I nuclei 
after 1-hour stimulation with APCs plus 100 nM N4 or T4 OVA peptide, in the presence of titrated 
concentrations of PRN-694. Histograms shown are representative of 3 or more independent 
experiments. 











































































































3.9A,C). Interestingly, the proportion of Erk1/2 activation in OT-I cells 
appeared unaffected by treatment with PRN-694, but weaker T4 peptide 
stimulation reduced the responding fraction by almost half compared to N4 
(from ~75% to ~40%), indicating digital MAPK activation relies less on ITK 
activity under these conditions. 
 Measurement of NF-κB (p65) activation over the same 4-hour time 
course revealed either stimulation with weaker T4 peptide or ITK inhibition 
dampened the magnitude of the NF-κB (p65) nuclear fluorescence by two 
thirds (from ~75% to ~25%) (Fig. 3.9C). The effect of PRN-694 treatment was 
most apparent during N4 stimulation conditions, mirroring the effect during 
different peptide concentrations (Fig. 3.9C,B). Importantly, while weakened 
peptide stimulation or PRN-694 treatment reduced the proportion of NFAT1 
responding cells, NF-κB fluorescence was reduced within nuclei that were 
similarly NFAT1 positive (Fig. 3.9D). This indicated NF-κB activation was not 
directly dependent on the state of Ca2+/NFAT activation. NFAT1 translocation 
exhibited a lower threshold for digital activation, while p65 relied on stronger 
TCR input and the aid of ITK, albeit with less consistent translocation 
patterns on a per cell basis. 
 Titration of PRN-694 during N4 or T4 peptide stimulation further 
supported NF-κB translocation is consistently sensitive to ITK activity. 
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Because PRN-694 reduces the proportion of activated responders, I 
compared the NFAT1 and NF-κB MFI within only NFAT1 positive nuclei. 
PRN-694 titration progressively dampened the MFI of NF-κB (p65) within 
single N4 to T4 stimulated nuclei (Fig. 3.9E,D). NFAT1 MFI within NFAT1 
positive cells was more resistant to PRN-694 addition, especially during 
strong TCR stimulation. This was further evidence that ITK activity 
modulates the probability of all-or-none NFAT1 activation in single T cells 
(Fig. 3.9E). 
 While NFAT activation is directly influenced solely by activation of 
calcineurin, NF-κB proteins have multiple signaling entry points that can 
influence their activation (Lucas et al., 2004; Smith-Garvin et al., 2009). This 
includes DAG activation of IKK complex proteins as well as Ca2+ activation of 
CaM kinases (Ishiguro et al., 2006). As ITK activity is upstream of both DAG 
and Ca2+, it could possibly have multifactorial control over NF-κB. The 
experiments above show NF-κB activation is not directly dependent on 
NFAT1 activation state, however the highest NF-κB (p65) MFI for any 
stimulation condition was usually within NFAT1 positive cells, which may 
reflect additive Ca2+ and DAG influence as NF-κB inputs.  
 To separate DAG and Ca2+ components of NF-κB activation in OT-I 
cells, PMA or ionomycin was supplemented to wells of OT-I cultures during 
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N4 stimulation with or without PRN-694. Ionomycin addition to cultures 
during N4 stimulation did not modify the NFAT1+ fraction (which was already 
>90% responders) or modulate the NFAT1 fluorescence intensity, but did 
increase the proportion NFAT1 responders during T4 stimulation as expected 
(Fig. 3.10A-B). Ionomycin alone (in the absence of peptide stimulation) was 
sufficient to maximally translocate NFAT1, but did not induce appreciable 
NF-κB translocation (Fig. 3.10A). Ionomycin supplementation during N4 or T4 
peptide stimulation increased NF-κB (p65) fluorescence intensity within 
individual nuclei, indicating the threshold of Ca2+ flux sufficient to 
translocate NFAT1 is not the same as the maximum contribution to NF-κB 








































Figure 3.10. PMA and ionomycin supplementation during peptide stimulation reveals 
synergistic NF-κB signaling activation. 
(A) Histograms depicting NFAT1 and NF-κB (p65) activation during 1 hour 100 nM N4 stimulation with 
(red) or without (blue) 50 nM of PRN-694 or received no peptide stimulation (dark grey). 1 µg/mL 
ionomycin or 12.5 ng/mL PMA was supplemented to wells were indicated. (B) FACS contour plots with 
adjust histograms comparing NF-κB (p65) and NFAT1 fluorescence in after the same stimulation 
conditions as in A, but with 100 nM T4 peptide stimulation. 
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N4 or T4 stimulated cells and easily recovered the defect in NF-κB signaling 
due to ITK inhibition with PRN-694. These experiments demonstrated that 
under physiological peptide stimulation, separate downstream pathways are 
differently sensitive to the secondary messengers generated from the results 
of ITK activity. NF-κB activation relies more heavily on the amount of DAG, 
rather than Ca2+, to tune translocation. 
 These supplementation experiments also highlighted the synergistic 
nature of Ca2+ and DAG signaling in NF-κB activation. Either ionomycin or 
PMA individually improved p65 translocation in N4 or T4 peptide-stimulated 
T cells to some degree (Fig. 3.10A-B), but neither ionomycin nor PMA 
supplementation alone could produce NF-κB (p65) translocation as 
impressively as simultaneous stimulation with both. Precisely how DAG and 
Ca2+ signaling branches converge to maximize NF-κB is unclear. 
 Collectively, the experiments in this chapter provided evidence that 
activation of the NF-κB pathway can be modulated gradually via TCR 
stimulus or ITK activity, even within cells that digitally switch on other 
pathways such as NFAT or Erk. This demonstrated differential downstream 
signaling patterns exist in individual activating T cells experiencing slightly 
different TCR stimulation. 
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 A model of TCR downstream signaling can be arranged that 
summarizes the simultaneous and separate activation of NFAT, NF-κB, and 
MAPK in naive CD8+ T cells, including how ITK benefits each pathway 
differently (Fig. 3.11). MAPK and NFAT activation responded digitally at 
thresholded amounts of TCR signaling, represented by sharply transitioning 
activation curves (Fig. 3.11A). NF-κB activation was more gradual and 
Figure 3.11. Data summary of TCR signal strength effects on activation of separate signal 
pathways 
(A) Line plots depicting how ITK disproportionately shifts signaling thresholds. MAPK, NFAT, and NF-
κB responses are drawn in blue, green, and, red respectively. Activation response when ITK is present 
is drawn in a lighter shade; activation without ITK is drawn in a darker shade. Direction of the shift 
due to presence of ITK is indicated with an arrow. “TCR Stimulation” input is plotted against the 
resultant degree of “Activation.” (B) Summary of TCR signal strength control of pathway activation 
within a stimulated population. Groups of curves representing single cell MAPK (blue), NFAT (green), 
and NF-κB (red) responses to either “strong” (light shade) or “weak” (dark shade) stimulation are 
presented over time. Histograms to the right represent average “snapshots” of pathway activation of 



























required stronger TCR stimulation to achieve robust activation. ITK activity 
provided least benefit to MAPK, shifting the threshold slightly, and and a 
greater effect on NFAT, but the response of each remained digital. NF-κB 
activation benefited most from presence of ITK, as it enhanced the 
magnitude of activation. 
 Tracking hypothetical single cell trajectories over time depict TCR 
signal strength has control over the rapidity and fractional response of MAPK 
an NFAT activation in a stimulated clonal T cell pool (Fig. 3.11B). Strong 
signaling converts greater percentage of NFAT and MAPK responders in a 
shorter period of time, while weaker signaling converts a reduced fraction of 
responders over a longer period of time. Precision of when individual cell 
responses occur are less predictable during weaker signaling conditions. For 
NF-κB however, weaker signal strength has the effect of delaying activation 
and reducing the maximum intensity of the response, which is evidence of 
graded amounts of activation. Accompanying histograms provide 
hypothetical population ‘snapshots’ of the single cell trajectories drawn in 




 The experiments presented in this chapter offer three main findings 
that provide new insight into the simultaneous orchestration of signaling 
pathways downstream of TCR triggering in naive T cells: First, they illustrate 
a more complete appreciation of the probabilistic nature of T cell activation. 
Within a stimulated clonal pool, extracellular constraints such as peptide 
dose and affinity, and activity of intracellular TCR proximal machinery 
including ITK, all independently regulate the proportion of digitally 
responding T cells. Second, within cells that digitally trigger the TCR, 
downstream pathways still can respond separately. Digital NFAT and Erk1/2 
activation in OT-I cells are sensitive to different strength of TCR input, 
indicating they trigger at different thresholds. NF-κB activation consistently 
required stronger signal strength than NFAT1 to elicit robust activation and 
was most sensitive to ITK inhibition. Third, these experiments provide 
evidence for graded signaling patterns within activating cells, modulated in 
part due to ITK activity. Varying peptide affinity, dose, or treatment with ITK 
inhibitor modulated the fraction of digital NFAT1 responders, but dynamically 
controlled discrete amounts of NF-κB translocation. NFAT nuclear intensity 
was consistent under chemical stimulation with PMA/ionomycin, whereas 
those same conditions maximized NF-κB translocation, surpassing the limits 
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of peptide stimulation. Together, these data expand the understanding of a 
functional role for ITK in amplifying TCR signals: ITK activity lowers the TCR 
stimulation requirement for downstream pathways unequally, as separate 
pathways embody differing sensitivity to ITK-regulated messengers DAG and 
Ca2+ flux. 
 A primary goal for this research was to better understand the function 
of ITK. Since its discovery, great strides have been made in characterizing its 
expression and molecular regulation, as well as the discovery of its function 
in catalyzing PLC-ɣ1 activation (Andreotti et al., 2010). Yet mystery enshrouds 
ITK, as it is a relatively weak kinase within the Tec kinase family and its 
activity is not absolutely required for T cell activation (Andreotti et al., 2010; 
Joseph et al., 2013). Some of the earliest studies demonstrated that Itk-/- mice 
can clear LCMV, vaccinia virus (VV), and vesicular stomatitis virus (VSV) 
similar to controls, albeit with slower effector T cell proliferation rate and 
weaker viral clearance kinetics (Atherly et al., 2006; Bachmann et al., 1997). 
Because primary Itk-/- T cells exhibited dampened downstream Ca2+ and Erk 
signaling, it is thought ITK functions to amplify TCR intracellular signals and 
is not an all or none component to the TCR machinery. The data in this 
chapter adds to this concept. It is now clear that ITK does amplify 
downstream signals, but differentially lending aid to specific pathways. NF-
κB receives more benefit to ITK activity than NFAT or MAPK. 
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Digital calcium and NFAT signaling in activating T cells 
 My initial hypothesis proposed TCR signal strength and ITK tuned 
graded Ca2+/NFAT signaling in a graded manner; implied from the ability of 
ionomycin to tune graded IRF4 expression. Examination of NFAT1 activation 
in peptide-stimulated nuclei did not support this hypothesis. I consistently 
measured clear, digital NFAT1 behavior switching on in OT-I cells. Peptide 
dose, affinity, or ITK inhibitor all modulated dynamics of the responder 
fraction of the OT-I pool. Digital NFAT1+ activation in primary mouse and 
human T cells has been reported previously (Podtschaske et al., 2007). 
However, the experiments presented here utilized careful control of TCR 
signaling inputs to reveal NFAT1 behavior in clonal cells, as well as further 
simultaneous comparisons with other signaling pathways. 
 Store operated calcium entry (SOCE) can be thought of as an all or 
none event. Ca2+ depletion from the ER triggers STIM1/2 activation and rapid 
extracellular Ca2+ entry through ORAI channels in the plasma membrane 
(Trebak and Kinet, 2019). These events can occur in oscillations, made up of 
Ca2+ flux and refectory periods. Using an encoded calcium biosensor, Andrey 
Shaw and colleagues were able to measure patterns of Ca2+ flux in peptide-
stimulated OT-I cells (Le Borgne et al., 2016). They observed transient, 
oscillatory, and sustained calcium flux patterns quickly after contact with 
APCs. Lowering peptide dose or affinity mildly decreased the percentage of 
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sustained Ca2+ responders and increased the percentage of oscillatory 
responders. NFAT1 proteins are rapidly de-phosphorylated by calcineurin 
and import to the nucleus quickly after the initial Ca2+ flux, but the NFAT 
nuclear export rate is slower, likely allowing NFAT to persist in the nucleus 
through refectory periods of Ca2+ oscillations, which can offer “signal 
memory” (Marangoni et al., 2013; Okamura et al., 2000). In the experiments in 
this chapter, NFAT1 persisted in the nuclei of responder cells for hours after 
initial contact. While the discrimination of cells based on sustained vs. 
oscillatory Ca2+ flux is possible, both states may induce similar patterns of 
NFAT activation. The maximum percentage of NFAT1 responders was 
dictated by TCR peptide affinity, dose, or ITK inhibition. This limit may have 
underlying correlation with the ratio of sustained/oscillatory and transient 
responders.  
 Conventional measurement of Ca2+ flux in T cells is performed by 
calculating the ratio of two calcium sensitive fluorescent dyes in a stimulated 
pool on a flow cytometer observed over time. This assay was critical in 
identifying initial Ca2+ signaling defects in ITK deficient mice (Atherly et al., 
2006; Schaeffer et al., 1999). Because each cytometer event is a different cell, 
the results represent an average of the Ca2+ flux within the population. 
Representations of fractional Ca2+ responses within the population are lost. 
Utilizing flow cytometry of isolated stimulated cell nuclei, the experiments 
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presented here offer improved analyses which measure responder and non-
responder Ca2+/NFAT1 fractions within the stimulated pool. Weaker 
stimulated OT-I cells consistently exhibited slower NFAT1+ conversion than 
stronger stimulated cells, which may be an example of the probabilistic 
nature of NFAT activation behaving as a digital switch, or alternatively, may 
be indicative of inherent heterogeneity within naive T cells. Another study 
cleverly monitored single OT-I cell Ca2+ responses by tracking hundreds of 
individual peptide-loaded APCs and naive OT-I cell pairs in microfluidics 
chambers (Dura et al., 2015). Similar to NFAT1 results here, they 
demonstrated that OVA peptide concentration modulates the overall fraction 
of cells that spike Ca2+ and the rapidity of the population conversion. The 
benefit of single cell tracking made it clear strong TCR signals appeared to 
condense the period during which single responder cells spiked Ca2+, 
appearing more synchronous. Weaker signaling delayed and dilated the 
period of response, with individual Ca2+ spikes appearing more scattered 
across the population. Importantly, individual cells that exhibited strong, 
rapid Ca2+ spike after peptide stimulation were more likely to exhibit similar 
patterns during repeat stimulation. This was an indication for heterogeneity 
of signaling capabilities inherent within a clonal OT-I pool. Whether 
fractional NFAT1 (and similar patterns that can apply to Erk1/2) responder 
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populations are due heterogeneity or are a manifestation of probabilistic 
effects of TCR triggering is still not clear. 
Signal strength and T cell motility 
 Although not directly addressed here, another important factor linking 
TCR signal strength to the kinetics of T cell activation is the effect of cell 
motility. Previous in vivo imaging experiments tracked naive T cell 
interactions with dendritic cells within live mouse lymph nodes and 
discovered that early activation can be divided into three temporal phases 
(Mempel et al., 2004). T cells first scan, a period where they have many brief 
encounters with DCs, followed by a second period of stable interactions, and 
finally a third phase of rapid proliferation and motility. A subsequent study 
revealed that the duration the T cell scanning phase is largely controlled by 
the concentration of presented peptide on DCs (Henrickson et al., 2008). 
Weaker stimulated cells scanned for longer periods of time before 
transitioning to form stable DC contacts. Also, splenic CD8+ T cells that 
encountered weak affinity peptides during Listeria infection migrated to the 
blood sooner than T cells that encountered strong affinity peptides (Zehn et 
al., 2009). Thus weakest affinity clones are less expanded and often found at 
the site of infection first. Others have rationalized these mechanisms would 
83
maximize the expansion of clones that experienced highest-affinity 
interactions. 
 Whether signal strength control of cell motility has a role in the 
activation kinetics of OT-I cells in the ex vivo stimulation experiments 
presented here is not clear. Evidence for “three phase” T cell activation 
without lymph node structures or stromal cells in culture dishes is also 
lacking. There is evidence of a role for ITK in actin polymerization, which is 
critical in cytoskeletal rearrangement and cell polarization to appropriately 
form contacts with APCs (Comrie and Burkhardt, 2016; Dombroski et al., 
2005). Itk-/- mice or reduced ITK expression in Jurkat cells exhibited 
disrupted actin polymerization, with decreased activation of Wiskott-Aldrich 
syndrome protein (WASP) and decreased recruitment of the guanine 
nucleotide exchange factor Vav (Dombroski et al., 2005; Labno et al., 2003). 
Rescue with a kinase-inactive form of ITK was sufficient to reestablish actin 
polymerization and Vav recruitment. This suggested that ITK had a kinase-
independent scaffolding role during activation-associated actin 
reorganization. Studies of T cell cytolytic function suggest that Itk-/- T cells 
can form synapses with target cells normally; whether this extends to naive 
cell contacts with APCs is untested (Kapnick et al., 2017). 
 Experiments in this chapter utilized PRN-694, a small molecule 
covalent inhibitor of ITK kinase activity, so it is plausible that scaffolding 
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functions of ITK could remain and measured temporal defects in signal 
pathway activation within ITK-inhibited cells are not due to decreased cell 
motility or actin polymerization (Zhong et al., 2015). Broad motility defects in 
activated mature T cell and autoreactive T cell migration in the periphery 
due to ITK deficiency have been described, but whether this is due to 
cytoskeletal organizational defects or dysregulation of cell surface adhesion 
molecules and homing receptors is not clear (Cho et al., 2020; Jain et al., 
2013). Imaging experiments which track OT-I and APC interactions could be 
performed to investigate the degree at which TCR signal strength or ITK 
activity regulate OT-I cell motility in vitro stimulations with APCs. 
Digital Erk1/2 signaling in naive T cells 
 Early experiments revealed that Erk1/2 activation was dampened in 
Itk-/- T cells (Atherly et al., 2006; Schaeffer et al., 2000; Schaeffer et al., 
1999). Therefore it was surprising to see that Erk1/2 phosphorylation was 
insensitive to treatment with ITK inhibitor PRN-694 under conditions that 
reduced NFAT1 responders and reduced the magnitude of NF-κB 
translocation. However, it is noted that ITK deficiency also has minimal effect 
on digital CD69 expression at 24 hours (Conley et al., 2020). Bimodal CD69 
expression, which is utilized as an early surface marker for T cell activation, 
correlates strongly with digital Erk1/2 activation patterns (Das et al., 2009; 
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Roose et al., 2007). Thus, CD69 expression patterns in Itk-/- mice may 
reflect earlier Erk1/2 behavior, supported by ITK inhibitor experiments 
presented here. 
 Later studies and the experiments in this chapter, measured strong 
digital pErk1/2 behavior in OT-I cells following stimulation with peptide:MHC 
on APCs (Altan-Bonnet and Germain, 2005). This behavior was found to be 
regulated by a positive feedback mechanism involving LAT-associated Grb2-
SOS (Das et al., 2009). Serial TCR interactions with antigen generate analog 
accumulation of active Ras proteins via RasGRP in the TCR proximal 
environment. When Ras surpasses a threshold, positive feedback of SOS is 
triggered, which leads to digital activation of the MAPK cascade including 
Erk1/2. While PLC-ɣ1 production of DAG helps enhance RasGRP activation 
prior to SOS activation, PMA stimulation alone (a DAG mimic) bypasses TCR 
ligation and does not recruit Grb2-SOS, and displayed analog Erk1/2 
activation through direct DAG-PKC-RasGRP-Ras-Raf signaling (Das et al., 
2009; Roose et al., 2007). It is possible that DAG is not limiting in triggering 
SOS and dampened amounts of DAG generated when ITK is inhibited remain 
sufficient to elicit digital activation of Erk1/2. This could account for a lack of 
an effect of PRN-694 addition in my experiments. 
 Most of the Erk1/2 defects measured in early ITK knockout studies 
were via immunoblotting whole cell lysates from anti-CD3 antibody-
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stimulated mouse T cells or Jurkat cells (Atherly et al., 2006; Schaeffer et al., 
2000; Schaeffer et al., 1999). Fundamental differences between anti-CD3 
stimulation and peptide:MHC stimulation are possible. One study comparing 
antibody stimulation and peptide stimulation reported soluble anti-CD3/
CD8+ antibody stimulation induced immediate and more intense p-Erk1/2 
activation in OT-I cells when were normalized to activation or other TCR 
proximal molecules (e.g. Zap70, LAT), while stimulation with conjugated 
SIINFEKL (OVA) peptide:MHC multimers was relatively weaker and delayed 
(Wang et al., 2008). Perhaps only presentation of physiological MHC 
multimers can organize TCR proximal machinery, promote conformational 
changes in TCR/CD3 complexes, as well as segregate phosphatases to 
properly regulate kinetic proofreading and ligand discrimination. Likewise 
crosslinking the TCR with soluble anti-CD3 may bypass any nuance 
associated with kinetic proofreading mechanisms of ligand discrimination 
and signal cascades. 
 p-Erk1/2 measurements here were made from separate (often plate-
copied) replicates, but unfortunately not measured within the same cells that 
were used for simultaneous NFAT1 and NF-κB measurements. A caveat of 
nuclear preparation of samples is loss of ability to measure cytosolic 
proteins, including phosphorylated Erk1/2. Further, the p-Erk1/2 
measurements were made from methanol-permeabilized cells, while isolated 
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nuclei were permeabilized with detergent reagents. Therefore, simultaneous 
measurement of p-Erk, NFAT, and NF-κB activation was not achieved. Ideally 
it would have been advantageous to measure all pathways within the same 
cells. This could be accomplished with imaging flow cytometry approaches 
that observe nuclear NFAT and NF-κB translocation and phospho-Erk1/2 
fluorescence while not disrupting cell membranes. 
TCR signal strength regulates graded NF-κB activation 
 A previous investigation into the behavior of NF-κB in naive T cells 
concluded TCR ligation triggered digital activation (Kingeter et al., 2010). 
They observed phosphorylation and degradation of inhibitor of κB (IκB)⍺ and 
phospho-RelA in CD4+ and CD8+ T cells after stimulation with anti-TCRβ 
antibodies. However, the data presented in this chapter suggest otherwise, as 
NF-κB activation was less digital and more analog, especially as peptide 
stimulation was weakened or ITK was inhibited. This may be due to 
differences in stimulation conditions (antibody mediated TCR cross-linking 
vs peptide:MHC stimulation). Under the strongest stimulation conditions 
tested here (native N4 OVA peptide), NF-κB (p65) translocation was relatively 
fast and complete, but no stimulation conditions produced bimodal 
responses. Another study inhibited calcineurin with cyclosporinA in primary 
mouse and human T cells and reported a decrease in digital NFAT signaling 
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and a graded decrease in NF-κB activation (Podtschaske et al., 2007). This 
also highlighted the multiple signaling inputs, including DAG and Ca2+, that 
converge on NF-κB activation. 
 The canonical NF-κB pathway describes DAG activation of PKC-Θ, and 
subsequent activation of the CARMA1-Bcl10-MALT1 (CBM) complex, leading 
to IKK complex activation. Active IKK complex phosphorylates IκB⍺, marking 
it for ubiquitylation and degradation (Cheng et al., 2011; Gerondakis et al., 
2014; Lucas et al., 2004). While DAG activation is critical for NF-κB, there is 
evidence that supports a calcium component to NF-κB signaling. One group 
found that following TCR stimulation, calcium-sensitive calmodulin-
dependent protein kinase II (CaMKII) enhances activation of CARMA1 and 
subsequent NF-κB activation (Ishiguro et al., 2006). Another important, early 
study carefully modulated intracellular Ca2+ levels in primary B cells and 
revealed differential NFAT and NF-κB responses (Dolmetsch et al., 1997). They 
observed NF-κB responded to transient, large increases in Ca2+ and NFAT 
activation was controlled by less intense, but more sustained Ca2+ levels.  
 My data may support a role for calcium in NF-κB activation, as both 
ionomycin and PMA supplementation during peptide stimulation enhanced 
NF-κB (p65) translocation. PMA alone unsurprisingly elicited NF-κB 
activation, but ionomycin alone did not. This could be due to complete lack 
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of CARMA1 activation in Ca2+ only conditions. The results do suggest 
however, that DAG component to NF-κB activation is likely more important. 
There may be a dynamic amount of DAG required to robustly activate NF-κB, 
and ITK inhibition, or weaker TCR stimulation, may lower DAG abundance 
considerably. The second messengers DAG and IP3 are produced in 
equimolar amounts when PIP2 is digested by PLC-ɣ1, but the data here 
highlight that different pathways may have differing requirements of 
thresholds and sensitivity to each messenger for activation. 
 Another insight is a new perspective on the limitations of signaling 
within naive cells. T cells interacting with APCs in a lymph node during a real 
infection experience varying intensity of co-stimulation that further 
amplifies activation states (Chen and Flies, 2013). The importance of “signal 
two” is well-described and paramount for a robust in vivo T cell response. 
NF-κB in particular is very sensitive to PKC-Θ and PI3K activation due to 
CD28 ligation and responds to activation of TNF family receptors such as 
4-1BB and OX40 (Chen and Flies, 2013; Schmitz and Krappmann, 2006). CD28 
enhanced NF-κB activity is key in regulating transcription at the Il2 promoter 
and inducing survival factor Bcl-xL, among numerous other roles (Boise et 
al., 1995; Marinari et al., 2004; Schmitz and Krappmann, 2006). In my 
experiments, PMA and ionomycin synergize to produce NF-κB activation far 
surpassing the strongest peptide stimulation conditions. These observations 
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underscore the need for co-stimulation and suggest graded NF-κB signaling 
in naive cells may act as a mechanism to tune the scale of functional, 
expanded T cell populations. 
Novel use of a nuclei isolation assay for flow cytometry 
 Most of the data in this chapter were gathered using an innovative 
approach that measures translocation of transcription factors in isolated 
single T cell nuclei using conventional flow cytometry (Gallagher et al., 2018). 
Initially, I and others in my lab attempted to pursue imaging flow cytometry 
technology (FlowSight), with some success, but found limitations in analyzing 
small, naive primary mouse T cells. Conventional flow cytometry analysis of 
isolated T cell nuclei has the benefit of easy access to reagents, has high 
sample throughput, and greater fluorophore selections only limited by the 
cytometer. Combined with my methods for analysis of mixed primary cell 
stimulations using cell proliferation dyes, this assay is quickly adaptable and 
already proven to be a powerful tool to the Berg Lab and our collaborators. 
Some limitations exist however. One should be aware of the inability to stain 
surface proteins, due to removal of the plasma membrane. Additionally, many 
protein factors are not regulated via sequestration in the cytoplasm, thus 
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activation states may not be quantifiable by measured nuclear protein 
content. 
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Chapter IV: ITK control of early gene transcription in activating CD8+ T cells 
ITK control of early gene transcription 
in activating CD8+ T cells 
Preface 
This chapter encompasses the principal findings presented in the following 
manuscript: 
1. Gallagher MP, Conley JM, Vangala P, Garber M, Reboldi A, Berg LJ. The 
Tec Kinase ITK Differentially Tunes Graded TCR Downstream Signals 
During Early T Cell Activation. TBD (2020). 
Summary 
 After 24 hours of activation, T cells express graded amounts of the 
transcription factor IRF4 dependent on the strength of TCR stimulus and 
level of ITK activity. To determine the extent TCR signal strength regulates 
the earliest gene transcription in naive cells, RNA-seq and ATAC-seq was 
performed on OT-I cells peptide-stimulated up to 2 hours, with or without 
treatment with ITK inhibitor PRN-694. A similar transcriptional profile was 
detected in all samples, independent of TCR signal strength, indicating a 
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single activation transcriptional program. Within the group of earliest genes 
detected (primary response genes) differential expression effects were 
observed. ITK inhibited cells had significant decrease in expression of 
nascent AP-1 transcription factor members, such as Fos, Fosb, and Fosl1, and 
NF-κB response genes. There was little difference in expression of Egr family 
members Egr2 and Egr3 and Nr4a family members. c-Fos protein 
accumulation was also limited in PRN-694 treated T cells. ATAC-seq 
experiments revealed early changes in chromatin sensitive to PRN-694 
treatment were enriched for AP-1 and NF-κB motifs. These transcriptional 
patterns highlight how TCR signals can modulate accumulation of early gene 
products in cells and may be the consequences of differential TCR signaling 
patterns described in Chapter III. 
Introduction 
 Prior to delayed effector-associated expression of genes like IRF4 that 
peak after 24 hours, naive T cells first undergo waves of transient, primary 
response gene (PRG) transcription that begin to change the metabolic and 
transcriptional state. These genes are the “first responders” to TCR-
dependent transcription factor binding and activity (Fowler et al., 2011; 
Herschman, 1991; Tullai et al., 2007). Similar patterns of PRG expression are 
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found in many cell types where signaling causes exit from a quiescent state 
and entry to a metabolic state. Studies in receptor tyrosine kinase signaling 
revealed that first wave PRG transcripts such as Fos, Jun, and Myc do not 
accumulate appreciably, due to high AU-rich content marking them for 
degradation (Mayya and Dustin, 2016). While presence of PRG mRNA is short, 
there is evidence that T cells accumulate PRG products over longer durations 
as the result of sequential periods of TCR signaling (Clark et al., 2011). 
 While conducting signaling studies, it was becoming clear to me that 
most of the downstream signaling responses appeared digital with exception 
to NF-κB, which was specifically sensitive to weakened TCR stimulation or 
inhibition with ITK inhibitor PRN-694 (Chapter III). I hypothesized these 
differential signaling conditions have immediate effects on the balance of 
NF-κB-mediated PRG transcription transcription in stimulated naive OT-I 
T cells. If so, could these effects carry forward throughout later periods of 
activation? 
 A critical role for NF-κB in regulating T cell activation programming is 
clear. For example, NF-κB is important in upregulating survival factor BcL-xL 
(Boise et al., 1995). Early studies of the Il2 promoter indicated that NF-κB p65 
had an active role in Il2 binding and early IL-2 expression (Jain et al., 1995). 
Induced NF-κB protein c-Rel also assists in IL-2 expression throughout T cell 
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activation. However, much of the literature is focused on combined TCR 
signaling and co-stimulation signaling via CD28 and TNF-family receptors 
that amplify NF-κB through intermediates like PI3K activity (Schmitz and 
Krappmann, 2006). It has been observed co-stimulation, cytokine signaling 
and continued TCR signaling all sum linearly to regulate T cell expansion late 
into the activation program (Marchingo et al., 2014). Thus, it was unclear 
whether NF-κB signaling plays a limited or active role in regulating the 
earliest waves of primary gene transcription.  
Results 
TCR signal strength and ITK control of early gene transcription 
 To evaluate the immediate transcriptional response during variable 
TCR signaling conditions, naive OT-I cells were stimulated in cultures with 
either N4 or T4 altered OVA-peptide loaded WT splenocytes, similar to the 
experimental conditions in Chapter III. To determine the extent of immediate 
transcriptional effects due to ITK activity, cells were also cultured with or 
without the ITK inhibitor PRN-694. cDNA libraries were then generated from 
sorted OT-I cells after 30, 60, or 120 minutes of stimulation. A distance 
matrix of variance-stabilized sequenced library results showed that sample 
replicates clustered similarly by stimulation condition (Fig. 4.1A). PCA analysis 
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revealed replicates grouped similarly, indicating largest variance components 
across samples were likely due to stimulation time and stimulation 



















































































































Figure 4.1. RNA-seq replicate correlation and principal component analysis 
(A) Sample-to-sample correlation to compare RNA-seq replicates. (B-D) Principal component analysis 
of all RNA-seq replicates across all stimulation conditions.
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 Filtered, expressed transcripts were k-means clustered (k=6) and 
groups were ordered according to temporal gene induction patterns (Fig. 
4.2A-B). Clusters represented expression of immediate and delayed gene sets. 
The earliest gene groups (Clusters I and II) represented genes with transient 
abundance, with decreased expression by 120 minutes. Cluster I exhibited 
peak expression 30 minutes after TCR contact with peptide:MHC and was 
enriched for TCR signaling-related ontology terms. This included “AP-1 
signaling,” “NF-κB signaling,” and “NFAT signaling” (Fig. 4.2C). This indicated 
that TCR downstream signaling pathways immediately and directly regulate 
transcription of these early genes. TCR downstream pathway-related terms 
were also enriched in delayed gene clusters (Clusters II, III), suggestive of the 
effects of continued TCR signaling. Clusters of delayed genes first detectable 
at times greater than 60 minutes were enriched for terms linked to T cell 
effector function, “Myc targets” and cell cycle regulation (Clusters IV, V), and 
IL-2 signaling (Cluster III), representing secondary gene transcription beyond 
immediate TCR control and likely regulated by a mix of continuing TCR 
signaling and first wave gene transcription. 
 Clustered arrangement of the data also indicated decreased quality of 
TCR signaling induced similar patterns of transcription, but at lower 
abundance. Weaker TCR stimulation (T4 stimulation, PRN-694 treatment, or 
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Figure 4.2. Inhibition of ITK dampens immediate TCR signaling-induced transcripts. 
(A) Heatmap depicting mean variance-stabilized transformed (VST) normalized expression values of 
top 357 genes (Log2 fold-change > 2, mean expression > 1000, p-adj < 0.1) induced in OT-I CD8+ T 
cells at three timepoints (30, 60, and 120 minutes) after stimulation with APCs plus 100 nM N4 OVA or 
T4 altered OVA peptide with or without 50 nM PRN-694. Genes were grouped with k-means clustering 
into 6 clusters. (B) Line plots depicting Z-score of 2-hour expression time course of gene clusters 
identified in A. Scores for mean expression values for each cluster are grouped by conditions in A; N4 
(blue), N4 + PRN-694 (red), T4 (orange), T4 + PRN964 (green). Total expression data for all conditions 
from three replicates are drawn in gray. (C) Enriched MSigDB signatures in gene clusters identified in 
A. Log10 transformed adjusted p-values (FDR) of (up to) the top 5 terms (p-adj. ≤0.05) from both 
“Hallmark Gene Sets” and “Immunologic Signatures” MSigDB collections. Cluster VI did not contain 
gene set enrichments with these constraints. Data represent three separate biological replicate 
experiments each utilizing pooled splenocytes from three or more OT-I mice. 
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(Fig. 4.2B). Whether an artifact of the limited resolution of pooled RNA-seq 
data or reflective of actual individual cell behavior, these results did not 
indicate any delay in gene induction during weaker stimulation conditions. 
For example, the earliest induced transcripts (Cluster I) peaked at 30 
minutes, but this pattern was not shifted to a later time point during weaker 
stimulation. Based on data describing NFAT, NF-κB, and Erk signaling 
(Chapter III), delayed or asynchronous transcriptional activity would be 
predicted in weaker-stimulated cells. 
 These experiments allowed us to interrogate the immediate 
transcriptional response to TCR engagement and revealed that modulation of 
upstream TCR signal strength activates, overall, similar transcriptional 
programming. Because there was evidence that TCR signal strength and ITK 
regulates differential patterns in signal activation (Chapter III) and 
differential gene expression at 24 hours (Conley et al., 2020), it was possible 
this was connected to induction of a separate transcriptional program. 
However, weaker stimulation with T4 peptide or ITK inhibition with PRN-694 
did not appear to induce a unique gene set. Differential expression analysis 
identified considerable overlap between significantly induced genes for each 
stimulation condition. While fewer genes were found to be significantly 
induced during weaker T4 stimulation (n=284) or PRN-694 (n=390) 
treatment, nearly all were also induced during N4 stimulation (n=487) (Fig. 
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4.3A-B). Similarly, nearly all of the induced genes during T4 with PRN-694 
stimulation were also found within the T4 stimulated induced genes (Fig. 

























































































































































































































































































































Figure 4.3. Graded TCR signaling induces a single transcriptional program. 
(A-C) Indicated overlap of induced genes identified in each tested TCR signaling condition. N4 = blue 
(n=487), T4 = orange (n=284), N4 + PRN-694 = red (n=390), T4 + PRN-694 = green (n=122). (D-E) The 
effect of stimulation with weaker affinity peptide vs treatment with PRN-964. Linear correlation of 
Log2 fold-change values determined by differential expression analysis of either N4/N4+PRN-694 or 
N4/T  comparisons at each time point.
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shared in weaker T4 peptide and PRN-694 treatment highlighted their 
similarities in transcriptional control (Fig. 4.3D-F). Whether modulating TCR 
stimulation or ITK activity, similar patterns emerged. This was further 
evidence that a determined initial transcription activation program is 
induced after TCR ligation.  
 Comparing select individual expressed genes demonstrated 
differential expression patterns. Some of the earliest genes detected 
included known immediate-early response genes, including AP-1 family 
proteins (Fos, Fosb) and Egr family genes (Egr2, Egr3), all found within 
Clusters I and II (Tullai et al., 2007). Peak Fos and Fosb transcription was 
dampened by either treatment with PRN-694 or weaker peptide stimulation 
(Fig. 4.4). Egr2 and Egr3 transcription appeared to be less sensitive, especially 
during PRN-694 treatment, where patterns of expression abundance 
appeared identical.  
 Nr4a family member transcripts (Nr4a1, Nr4a2, Nr4a3), also appeared 
less sensitive to PRN-694 treatment, especially during strong N4 peptide 
stimulation (Fig. 4.4). Recent work has discovered Nr4a family members 
(particularly Nr4a2, Nr4a3) are important in executing exhausted T cell 
programming and their regulation is largely attributed to NFAT activity (Chen 
et al., 2019; Jennings et al., 2020; Martinez et al., 2015; Mognol et al., 2017; Sen 
et al., 2016). As discussed in Chapter III, NFAT1 signaling was less affected by 
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PRN-694 treatment under the same stimulation conditions evaluated here. 
Based on other previous experiments, I expected NF-κB signaling to be 
weakened during PRN-694 treatment. Consequently, transcripts responsive 
Tnf Irf8 S1pr1 Tcf7
Il2 Il2ra Irf4 Ifng
Nfkbia Nfkbiz Nfkbid
Nr4a1 Nr4a2 Nr4a3
Fos Fosb Egr2 Egr3
0 30 60 90 120 0 30 60 90 120 0 30 60 90 120 0 30 60 90 120
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Figure 4.4. Example patterns of detected early transcripts. 
Line plots depicting normalized count data of selected gene transcripts over the course of the 2-hour 
RNA-seq experiment. Colors are consistent with other figures. Data represent three separate 
biological replicates. All genes presented are significantly differentially expressed compared to 
control at least at one time point. Error bars represent s.e.m.
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to NF-κB signaling (Nfkbia, Nfkbid, Nfkbiz) were among the most sensitive to 
PRN-694. 
 Differential expression analysis at 30 minutes of supported these 
patterns in expression. PRN-694 treatment dampened induction of select 
transcripts including those encoding Fos, Fosb, and Fosl, as well as Myc, NF-
κB response genes (Nfkbia, Nfkbid), but had less of an effect changing the 
relative expression of other induced transcripts like Egr family members 
(Egr1, Egr2, Egr3) and Cd69 (Fig. 4.5A). Similar patterns were found during T4 
stimulation, but not completely, as PRN-694 treatment did not dampen 
Nfkbia and Nfkbiz, and did lower relative Egr2 abundance (Fig. 4.5B). This 
difference observed when weakening peptide stimulation conditions may be 
attributed to a fractional response of the stimulated population, reflecting 
slower digital activation kinetics as discussed in Chapter III. 
 PRN-694 treatment or weaker peptide stimulation also dampened 
expression of delayed genes that encode important effector functions and 
scale the effector response. Transcription of Il2, Irf4, Il2ra (encodes CD25), 
Ifng, and Tnf all decreased with weaker TCR signaling conditions (Fig. 4.4). 
This is expected based on TCR signaling and ITK-deficient phenotypes in 
graded protein expression observed at 24 hours and indicates some of these 
expression patterns may be determined early on during activation. 
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 To determine whether immediate transcriptional changes due to TCR 
stimulation strength or ITK activity also lead to reduced early gene product 
accumulation during activation, I measured Egr2, c-Fos, c-Myc intracellular 
protein and CD69 surface expression in stimulated cells with flow cytometry 
(Fig. 4.6A-C). Both c-Fos and Egr2 proteins were detectable within 30 
minutes of OVA stimulation and their expression continued to be detected 
for at least 6 hours, beyond the time of their peak RNA transcript abundance. 
Treatment with PRN-694 or stimulation with T4 peptide dampened the 
maximum amount of c-Fos expression compared to N4-stimulated OT-I cells 
measured out to 6 hours. Weakened signaling had less effect on maximum 
Figure 4.5. Immediate transcripts are differentially sensitive to PRN-694 treatment.
(A-B) Volcano plots identifying transcripts sensitive to 50 nM PRN-694 treatment measured after 30 
stimulation of OT-I cells with APCs plus 100 nM N4 peptide (A) or 100 nM T4 peptide (B). Labeled gene 
names represent select early-induced transcripts significantly expressed compared to unstimulated 
controls, extracted from either clusters I or II from Fig. 4.2. Plots depict the Log2 fold change of 
normalized expression of untreated samples over PRN-694-treated samples against -Log10 
transformed FDR values. Data points and gene names significantly above FC cutoffs (Log2 fold change 
> 1, -Log10 FDR <0.1) are drawn in red; genes that were not significantly differentially expressed due 







Egr2, Myc, and CD69 expression. After 6 hours all 4 stimulation conditions 
were beginning to converge in protein expression, with exception to c-Fos. 
Evident in the bimodal patterns of the flow cytometry histograms, Egr2, Myc, 
and CD69 appeared to activate digitally, while c-Fos expression was 
modulated in incremental amounts, appearing more graded (Fig. 4.6C). 


















































































































120 min. 360 min.
Figure 4.6. TCR signaling and ITK control graded accumulation of early gene product c-Fos. 
(A) Line plots of mean normalized expression counts of select induced transcripts measured at 0, 30, 
60, and 120 min similar to Fig. 4.4. (B-C) Line plots (B) and representative histograms (C) of flow 
cytometry results for gene products of transcripts profi led in A. Experiments were conducted under 
similar stimulation conditions and previous figures and stimulated up to 6 hours. Results are plotted 
as % positive or normalized to maximum MFI (% max MFI) where indicated. (D) Representative 
histograms depicting graded c-Fos fluorescence in CD69+ Egr2+ OT I cells in response to different 
stimulation conditions measured after 6 hr. Labeling is consistent: N4 - blue (circles), N4 +PRN - red 
(squares), T4 – orange (diamonds), T4 +PRN694 – green (triangles). Data represent three biological 
replicates. Error bars indicate s.e.m.
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accumulated incremental amounts of c-Fos dependent on the TCR 
stimulation strength and ITK inhibition (Fig. 4.6D). These results confirmed 
that ITK signaling contributes to differential and graded gene expression in 
response to variations in TCR signal strength. 
ITK regulation of early changes in DNA accessibility 
 To connect differential individual TCR signaling pathway behavior with 
control of immediate gene expression patterns, I measured immediate, 
genome-wide DNA accessibility changes with ATAC-seq and analyzed 
enrichment of transcription factor binding motifs using HOMER (Buenrostro 
et al., 2013; Heinz et al., 2010). Cells for ATAC-seq analysis were split and 
sorted from those used in RNA-seq experiments, to better directly compare 
accessibility changes with gene expression. Thus, samples were stimulated 
with either N4 or T4 peptide, with or without PRN-694 for 30, 60, or 120 
minutes. 
 ATAC-seq replicates clustered together when plotted with PCA, 
indicating that variance was attributed to differences in stimulation. Similar 
to patterns found in transcriptome analysis, the strength of the TCR 
stimulation or ITK inhibition did not regulate an independent set of genomic 
regions, but rather regulated the intensity of a shared set of activation-
associated pileups. Compared to naive, unstimulated OT-I cells, strong N4 
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Figure 4.7. Early ITK-dependent changes in DNA accessibility are enriched for NF-κB and AP-1 
binding motifs.
(A) Distribution of ATAC-seq fragment distance from peak centers. Comparison of 120-minute 
stimulation with N4 peptide (blue) and unstimulated OT-I nuclei (grey). (B) Volcano plot of 
differentially-accessible genomic peak regions after 30 minutes of stimulation with N4 peptide. (C) 
Volcano plot of differentially accessible peak regions due to PRN694 treatment after 30 minutes of 
N4 peptide stimulation. Annotations of closest gene TSS are labeled for select regions. For B and C, 
significantly differentially accessible regions (Log2 fold change < -1 or > 1 and p-adj < 0.1) are drawn 
blue. (D) Heatmap and HOMER de novo motif enrichment analysis of k-means clustered Log2 
transformed and row-scaled peak regions after 30 min of either 100 nM N4 or T4 peptide stimulation 
with or without 50 nM PRN694 (N4 untreated, blue; N4 + PRN694, red; T4 untreated, orange; T4 + 
PRN694, green). n=9,907 significantly-differentially regulated regions compared to unstimulated in at 
least one peptide stimulation condition (Log2 fold change < -1 or > 1 and p-adj < 0.1). Displaying top 
(p-adj < 10-50) de novo motifs for each cluster. (E-F) ATACs-seq genomic tracks for regions around Irf4 
and Fosb loci comparing different peptide and PRN694 stimulation conditions after 30 minutes. Also 
plotted are ionomycin or ionomycin + PMA stimulation ATAC-seq peaks and NF-κB ChIP-seq peaks 
(Mognol et al, 2017; Oh et al., 2017). Differential experimental ATAC-seq peaks are highlighted in 
yellow.
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most evident after 120 minutes (Fig. 4.7A). After only 30 minutes of N4 
stimulation, about 10,000 DNA regions displayed differential accessibility 
compared to unstimulated cells (Fig. 4.7B). To evaluate differential 
accessibility due to ITK inhibition, N4 stimulated cells with and without ITK 
inhibition were compared. After 30 minutes of stimulation, the most 
significant changes in accessibility due to PRN-694 were found near many 
gene loci also identified in early transcriptional data including AP-1 factors 
(Fosb, Jun), NF-κB response genes (Nfkbia, Nfkb1), and genes encoding 
transcription factors important in regulating effector function (Rel, Nfatc1, 
Irf4) (Fig. 4.7C). This indicated that while many genomic regions change in 
accessibility similarly during activation, the few that were most sensitive to 
PRN-694 also were near early genes that echoed the most sensitive gene sets 
found in the transcriptional analysis. 
 k-means clustering of all 30 minute activation-induced DNA 
accessibility changes (differentially-accessible compared to unstimulated 
control) for all sample conditions revealed regulation of regions that had 
increased dependency on ITK activity (Fig. 4.7D). Regions that were less 
accessible after treatment with the ITK/RLK inhibitor were significantly 
enriched for AP-1 (Fra1) motifs and NF-κB motifs. Regions that were less 
sensitive to PRN-694 treatment were significantly enriched for NFAT family 
motifs. The ATAC-seq results indicate that specific DNA regions were 
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differentially more reliant on ITK activity for optimal regulation. Based on the 
motif enrichment data, I interpret these accessibility changes to be due to, at 
least in part, decreased NF-κB signaling in ITK/RLK-inhibited cells. 
NF-κB signaling enhances select graded gene expression  
 One of the strongest phenotypes observed when measuring signal 
pathway activation was greater defects NF-κB signaling in response to 
weakened TCR stimulus or PRN-694 treatment (Chapter III). PRN-694 
treatment dampened transcription and protein expression of select early 
genes (e.g. Fos, Fosb, Nfkbia) (Fig. 4.4, 4.5A, 4.6A-C). To evaluate the extent 
NF-κB signaling controls these expression patterns, OT-I cells were 
stimulated in the presence of a potent inhibitor of IκB kinase (IKK), IKK-16. As 
a comparison, the MEK inhibitor PD325901 was also used to measure 
activation without MAPK cascade activation. A titration of IKK-16 
demonstrated strong suppression of nuclear translocation of NF-κB (p65) 
with minimal effect on NFAT1 translocation or Erk1/2 phosphorylation after 1 
hour stimulation with N4 peptide (Fig. 4.8A). While Erk1/2 is well 
characterized as exhibiting digital activation following TCR ligation (Altan-
Bonnet and Germain, 2005; Das et al., 2009), titration of PD325901 gradually 















































































Fig. 4.8. Specific NF-κB inhibition differentially reduces c-Fos protein accumulation. 
(A-B) Histograms depicting effect of titration of IKK-16 (A) or PD325901 (B) on NFAT1, NF-κB, and p-
Erk1/2 activation after 1-hour simulation with N4 peptide. (C) Histograms demonstrating the effect of 
500 nM IKK-16 or 1000 nM PD325901 on c-Fos, Egr2, and CD69 protein expression in OT-I cells 
stimulated with N4 peptide for 2 hours. (D-E) Line plots of depicting 500 nM IKK or 1000 nM 
PD325901 treatment on c-Fos (D) and Egr2 (E) protein accumulation over 4 hours stimulation with N4 
peptide. Compiled are three separate experiments, error bars are s.e.m.
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translocation (Fig. 4.8B). This analog control of Erk1/2 phsophorylation is due 
to inhibition of MEK downstream of digital triggering events. Digital 
inhibition of Erk activation is achieved if a Src kinase inhibitor is utilized, 
which targets TCR proximal control of digital Ras activation (Vogel et al., 
2016).  
 OT-I cells were then stimulated with WT splenocytes loaded with N4 
peptide up to 4 hours, with or without IKK-16 or PD325901, and c-Fos, Egr2, 
and CD69 expression was measured with flow cytometry. Concentrations of 
IKK-16 and PD325901 were utilized that correspond to absent NF-κB and Erk 
activation respectively. During IKK-16 treatment, c-Fos expression displayed 
a greater defect in expression than Egr2 (Fig. 4.8C-E). This pattern was 
similar to the effect of inhibition of ITK with PRN-694 (Fig. 4.6). CD69 
expression was also dampened by IKK-16 (Fig. 4.8C). Treatment with 
PD325901 however, greatly reduced c-Fos, Egr2, and CD69 expression (Fig. 
4.8C-E). These results demonstrate a hierarchy in downstream TCR signaling 
pathway requirements for early gene expression. Specific genes are 
differentially sensitive to signaling conditions where NF-κB is absent, but 
others remain less affected. This suggests and auxiliary role for NF-κB during 
naive cell activation; amplifying gene expression in a graded manner. Under 
conditions where MAPK activation is limited, cells wholly fail to activate — 
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illustrating a dependency on all-or-none, digital MAPK activation under 
physiological signaling conditions. 
Discussion 
 Understanding ITK control of graded IRF4 expression during T cell 
activation has been a prime focus in the Berg lab (Conley et al., 2020; Nayar 
et al., 2012; Nayar et al., 2014). My own experimental efforts expanded upon 
these observations and attempted to connect TCR inputs and ITK activity 
with the intriguing patterns of gene expression observed at 24 hours. The 
experiments in this chapter aimed to determine whether graded TCR 
signaling and variable ITK activity have tunable control over the earliest gene 
induction in newly-activating naive OT-I T cells. They were designed to 
describe the extent of graded early gene expression and identify unique gene 
sets during signaling conditions derived from Chapter III, known to induce 
differential patterns of TCR downstream signaling pathway activation and 
transcription factor activation. 
 The results in this chapter can be summarized as four major findings: 
First, TCR stimulation of naive OT-I cells induces a predictable program of 
activation-associated transcription. Modifying TCR stimulation with variable-
affinity peptides or inhibition of ITK did not produce expression of unique 
gene sets. Instead, I observed waves of early and delayed gene sets consistent 
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across all qualities of stimulation. Second, ITK activity helps amplify the 
expression of specific groups of early transcripts. When ITK was inhibited 
during N4 stimulation, first-wave “immediate-early” genes such as Fos and 
Fosb, and NF-κB response genes displayed significantly decreased abundance 
during a short temporal window of expression. Third, ATAC-seq results 
suggest TCR signal strength control of early gene abundance is in part due to 
differences in AP-1 and NF-κB activity. This is because the DNA regions most 
dynamically regulated in response to ITK inhibition were enriched for AP-1 
and NF-κB binding motifs. The ATAC-seq experiments also compliment the 
concept of a single activation transcriptional trajectory in CD8+ T cells, as 
varied amount of TCR signal strength modulated the intensity of changes in a 
consistent set of DNA regions and did not regulate unique gene regions. 
Fourth, Graded early NF-κB signaling in naive T cells amplifies the magnitude 
of select genes, but is not absolutely required for activation, unlike digital 
activation of the MAPK signaling cascade. This was demonstrated using 
inhibitors of IKK and MEK, which created conditions of OT-I activation that 
lacked either NF-κB or MAPK signals. c-Fos protein expression was 
consistently more sensitive to NF-κB inhibition than Egr2. Differential 
protein expression patterns mirrored stimulation conditions during ITK 
inhibition with PRN-694 (Chapter III), which also produced weakened NF-κB 
114
activation. Overall, the experiments in this chapter contain novel 
observations about the nuance of graded TCR signaling and graded gene 
expression in early activating OT-I T cells. They also underscore a role for 
ITK in amplifying TCR signals to fine-tune the magnitude of select genes 
within a single, T cell activation transcriptional program. 
Single T cell responses 
 RNA-seq and ATAC-seq experiments were designed concomitantly 
with experiments in Chapter III that measured activation of individual signal 
pathways. At the time, the control of TCR signal strength on the kinetics of 
fractional responses within a stimulated population were not yet fully 
appreciated to properly interpret the data. Initial hypotheses were more 
focused on whether ITK could tune individual signal pathways than the 
temporal and probabilistic frequency of individual T cells within the clonal 
pool switching on activation-associated transcription. Thus, to evaluate 
peptide antigen and ITK control of early transcription, I chose to design 
pooled RNA-seq and ATAC-seq experiments.  
 After looking at the data from the first RNA-seq biological replicate, it 
was clear that there were some temporal factors that were significant to 
consider in interpretation of the data. Based on the signal pathway 
phenotypes in Chapter III, I knew that T4 peptide stimulation did not fully 
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switch on NFAT1, with about 75% responders. PRN-694 treatment during T4 
treatment reduced the NFAT1 responder fraction further to 50%. Therefore, 
when the same signaling conditions were used for pooled RNA-seq 
experiments, I should expect that much of the significant differential 
expression, especially between T4 and T4 with PRN-694 treatment, should be 
due to reduced fractional responses within the population, and less due to 
graded, differential signaling patterns. The ITK-specific effects during N4 
treatment are more preserved, because based on NFAT responses discussed 
Chapter III, the fractional responses during PRN-694 treatment are similar. 
For example, PRN-694 treatment during N4 stimulation significantly reduced 
expression of Fos transcripts at 30 minutes, but did not reduce Egr2 
transcript abundance. However, during T4 stimulations these kinds of 
differential relationships were lost, and PRN-694 treatment seemed to 
dampen all genes; likely due to a smaller proportion of activating cells. 
Therefore, I placed more weight on comparing N4 stimulation conditions 
than T4 stimulation conditions when interpreting the RNA-seq and ATAC-seq 
results discussed in this chapter. Yet I decided to include both N4 and T4 
stimulation conditions for presentation of some data, as it demonstrated that 
T cells experiencing weaker signaling utilize the same transcriptional 
program. 
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 To evaluate asynchronous activation of single cells and to counteract 
the effect of differing proportions of responding cells, single cell RNA-seq 
experiments were also considered. However, triplicate replicates of pooled 
RNA-seq and ATAC-seq experiments were completed. While single cell 
approaches excel in discerning unique transcriptional profiles within 
heterogeneous mixes of cells, it was not clear whether low copy number of 
nascent induced transcripts per cell would be sufficient to resolve minute 
differences in abundance within a similar set of genes induced by graded 
TCR stimuli. I noted that single-cell experiments would still be able to 
decipher fractional and asynchronous activation within populations. 
 In 2018, in an effort to evaluate how TCR signal strength regulates 
CD8+ effector cell fate and function, another group successfully tracked 
activation of single OT-I cells using multiple methods (scRNA-seq, 
conventional flow cytometry, mRNA flow cytometry, and mass cytometry) 
(Richard et al., 2018). They concluded that variable TCR stimulation 
conditions affect the proportion of T cell responders and the rate at which 
cells switch on, but the transcriptional “trajectory,” or progression through 
the activation program within each individual cell is similar. Weakly 
stimulated OT-I cells were less efficient in activation, but ultimately 
possessed the same full cytolytic capacity as strongly stimulated cells. My 
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experiments also supported the induction of a single activation-associated 
transcriptional program independent of TCR signal strength. 
 In the same single-cell study, the first-wave genes that were detected 
following strong N4 stimulation appeared similar to those reported from my 
dataset. Fosb, Nr4a1, Nr4a3, Egr1, Egr2, and Nfkbid are all among the highest 
abundance genes reported within 1 hour of stimulation. Curiously, they 
reported while weaker stimulation with T4 peptide reduced the fraction of 
responding cells that switched on, they did not detect notable graded 
abundance of those transcripts within single cells. These results agree with 
my experiments if the hidden fractional effects are considered. For instance 
Egr2 abundance is weakened by T4 stimulation, likely due to differences in 
smaller proportion of responders. My results however, test the role ITK 
during early activation, which primarily regulates second messenger IP3 and 
DAG production downstream of TCR proximal signaling regulation. During 
N4 stimulation, PRN-694 had little effect on reducing the fraction of NFAT1 
or Erk1/2 responders, yet had significant specific effects on reducing Fos, 
Fosb, and NF-κB response genes. Therefore, some form of future single-cell 
analyses testing PRN-694 would be beneficial to assemble a more complete 
picture of ITK control of early transcriptional activity within CD8+ T cells. 
Using single-cell RNA-seq or mRNA flow approaches, I would predict 
PRN-694 treatment would produce graded expression of the same select 
118
transcripts within individual OT-I cells. If T4 treatment did not induce graded 
expression of these genes, as reported in Richard et al., this would highlight 
an intriguing difference between proximal TCR signaling vs downstream 
regulation influenced by ITK. 
Early gene kinetics and function 
 Immediate-early primary response gene transcription in response to 
ligand-receptor interactions have been documented for decades 
(Herschman, 1991). Following receptor ligation, multiple waves of primary 
response gene transcription occur that do not require prior new protein 
synthesis (Tullai et al., 2007). In naive CD8+ T cells, it is reasoned that primary 
response genes may be, in part, under direct control of TCR signal pathway 
activation. Kinetics of nascent immediate gene transcription is rapid and 
transient. For instance, induced AP-1 factors (e.g. Fos, Fosb, Fosl1) are 
detectable within the first few minutes after receptor ligation, but are of 
small abundance after an hour, as noted in the patterns in my data.  
 Many transcripts detected in my datasets encode transcription factors 
that represent conserved early activation programs in many cell types. This 
includes AP-1 factors (e.g. Fos, Fosb, Fosl1), Nr4a family members, and Egr 
members. I observed specific defects in some of these transcripts (eg. Fos, 
Fosb) during weakened NF-κB signaling conditions. However, evidence for 
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direct NF-κB control of these genes is incomplete. A study of early and 
delayed primary gene transcriptional kinetics and genomic architecture 
found an over-representation of transcription factor binding sites upstream 
of immediate-early gene promoters including SRF, AP1, CREB, KROX and NF-
k ︎B (Tullai et al., 2007). There may be an important role for NF-κB members in 
regulation of some of these genes, but likely not solitary control. Aligning 
ATAC-seq pileups with publicly available NF-κB (p65) ChIP-seq data indicated 
that p65 may bind at differentially regulated regions near the promoter of 
genes like Fosb. However, future ChIP-seq experiments, or low input "Cut-
and-run" experiments could more directly measure NF-κB binding and 
evaluate the extent it is responsible for differential expression of genes like 
Fos or Fosb in my datasets (Skene and Henikoff, 2017). 
 The accumulation rate of immediate-early genes during early 
activation may be important in dictating the overall rapidity of the effector 
response and contribute to fitness of a T cell to sequentially signal. In the 
lymph node, T cells are able to scan activated APCs and make serial 
interactions with intermittent TCR triggering (Marangoni et al., 2013; Mempel 
et al., 2004). One research group compared c-Fos accumulation in stimulated 
T cells and reported the protein was stable for many hours after its induction 
and even after stimulus withdrawal (Clark et al., 2011). This echos the patterns 
in my data, where Fos transcript was detectable for only a brief 30-min 
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window after activation, but graded amounts c-Fos protein was detectable by 
FACS for at least 6 hours. They also reported T cells that briefly were 
stimulated prior to adoptive transfer into host mice had increased c-Fos 
expression and underwent more cell divisions after re-stimulation. Brief, 
sub-optimal TCR interactions may produce bursts of Fos transcript that lead 
to incremental accumulation of c-Fos protein. Thus, T cells can sum 
productive serial APC engagements to maximize activation potential. 
 Early studies in neurons determined TCF, serum response factor (SRF) 
and cAMP response element-binding protein (CREB) are important in 
regulating Fos transcription (Johnson et al., 1997). CREB activates in response 
to both PKC and Ca2+ signaling via calcium-sensitive CaM kinase activity 
(Johnson et al., 1997; Sheng et al., 1990; Sheng et al., 1991). In Chapter III, 
NFAT1 translocation was digitally regulated and less sensitive to ITK 
inhibition. Increasing calcium flux with ionomycin treatment did not increase 
NFAT1 intensity. While NFAT1 may have a specific threshold of Ca2+ levels that 
trigger digital activation, it is possible intracellular concentrations of Ca2+ 
may rise higher. In fact, high concentration of OVA stimulation induces 
greater intensity of Ca2+ flux as measured in single OT-I cells (Dura et al., 
2015). Future studies could test whether graded activation of early genes like 
Fos may be driven by calcium-sensitive transcription factors, such as CREB, 
in an NFAT-independent manner.  
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 For comparison, transcription of Egr2 and Egr3, two other immediate-
early genes with peak abundance after 30 minutes of stimulation, were less 
sensitive to PRN-694 treatment than genes like Fos. Egr2 and Egr3 are 
important in regulation the scale of T cell proliferation (Miao et al., 2017). 
They are NFAT target genes, and there is evidence that NFAT alone can drive 
Egr2 transcription (Marangoni et al., 2013; Martinez et al., 2015; Rengarajan et 
al., 2000). Therefore, patterns of Egr2 and Egr3 transcription may be 
attributable to digital NFAT activation that is less dependent on ITK activity. 
Cooperation of transcription factors 
 Regulation of activation-associated transcription involves the 
cooperation of many transcription factors. The Il2 promoter contains 
multiple sites for NFAT, NF-κB, and AP-1, which all bind to regulate 
transcription (Jain et al., 1995). Signal pathways that terminate with activation 
of different transcription factors may each activate independently, but many 
layers of redundancy and cooperation ensure only robust signaling 
conditions usher naive T cells from a quiescent state to a metabolically active 
effector state. 
 NFAT is known to associate with AP-1 proteins to cooperatively bind at 
NFAT/AP-1 binding sites to regulate gene transcription (Macian, 2005; 
Macian et al., 2001). Thus, genes that require NFAT:AP-1 interactions for 
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transcriptional activation, such as Il2, require sufficient, sustained TCR 
signaling conditions to activate the Ca2+/NFAT pathway and induce abundant 
AP-1 factors like c-Fos and c-Jun. Further, NFAT proteins can promiscuously 
interact with other AP-1 dimers aside from Fos/Jun. As described in my 
transcriptional analyses, c-Fos and FosB are quickly are transcribed within 30 
min and are potent transactivators. Other less potent AP-1 family members 
are transcribed later, such as Fosl1 (Fra-1), and may replace c-Fos in AP-1 
dimers to change the activating efficiency of NFAT:AP-1 and attenuating Il2 
transcription (Jain et al., 1995). 
 A 2017 study was intent on dissecting the transcriptional effects of the 
Ca2+ and DAG arms of TCR signaling. (Brignall et al., 2017). Using combined 
PMA and ionomycin stimulation of Jurkat cells, they discovered important 
synergistic effects. In reporter assays, the authors demonstrated that 
combined PMA and ionomycin treatment elicited far greater IL-2 expression 
and NF-κB activity than PMA or ionomycin alone, reflecting Il2 expression 
patterns kinetics I observed due to ITK inhibition, and capturing some of the 
nuances of NF-κB activation I observed in Chapter III. Combined PMA/
ionomycin treatment was vastly more potent in inducing chromatin 
remodeling compared to either PMA or ionomycin alone. ATAC-seq pileups 
due to combined PMA and ionomycin were specifically enriched NFAT/AP-1 
and NF-κB motifs, which were not found in regions accessible in PMA or 
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ionomycin alone. This is similar to my own results, where differentially 
accessible DNA regions during weakened TCR signaling via ITK inhibition 
were enriched for NF-κB and AP-1 motifs. This suggests strong TCR signaling 
conditions, which include robust NF-κB activation due to ITK assistance, 
optimally regulates activation-associated changes in chromatin. This study 
highlighted the importance of synergy among TCR signal pathways, which 
integrate at the chromatin level to regulate activation programming. 
 DNA binding sites within regulatory elements can also have variable 
affinity for transcription factors; another layer of control to tune graded 
transcriptional responses. In a recent study, researchers demonstrated 
groups of genes important in CD4+ T cell differentiation contain enhancers 
with high-affinity for IRF4-BATF transcription factor pairs (Gallagher and 
Berg, 2017; Iwata et al., 2017). Other groups of genes only contain low-affinity 
sites. Genes with high-affinity enhancers were induced under stronger TCR 
signal conditions, which generated greater graded amounts of IRF4 and 
BATF. Genes with low-affinity enhancers were expressed even under weak 
TCR signaling conditions. This demonstrated how graded TCR signal can 
differentially regulate transcription at the genome level. While TCR signals or 
ITK can regulate differential transcription factor activation in CD8+ T cells 
(Chapter III), individual patterns of activation-associated transcripts may be 
attributable to their specific genomic promoter and enhancer landscape. 
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 There is evidence NFAT proteins also can bind DNA alone, without 
AP-1 binding partners. In a 2015 study, Rao and colleagues reported 
persistent NFAT signaling present during chronic infections drives “NFAT 
alone” regulation of T cell exhaustion-associated transcriptional states 
(Martinez et al., 2015). They engineered a constitutively-active form of NFAT1 
that was unable to associate with AP-1 dimers and studied its DNA binding 
tendencies in mice. NFAT alone regulated increased expression of 
exhaustion-associated markers such as CTLA4, PD-1, TIM3, and LAG3. NFAT 
alone binding has also been shown to increase exhaustion-associated 
regulators Nr4a2 and Nr4a3 (Scott-Browne et al., 2016). Whether NFAT alone 
activity is contributing to patterns of Nr4a2 and Nr4a3 expression, or 
expression of other NFAT target genes Egr2 and Egr3 as described in my 
experiments, is not yet clear and could be focus of a future study (Rengarajan 
et al., 2000). 
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Chapter V: Discussion 
Interpretation of major findings: ITK function 
 The conclusions about differential signaling pathway responses to TCR 
signal strength presented here are novel and have broad implications about 
how graded signals are converted to analog cellular responses. While not the 
first to compare relative activation of NFAT, NF-κB, and MAPK responses, this 
dissertation carefully dissected components of graded TCR signaling (peptide 
affinity and dose) and intracellular signal modulation due to ITK in single 
cells (Dolmetsch et al., 1997; Podtschaske et al., 2007). Moreover, these 
experiments characterize a specific supportive role for ITK in TCR signal 
transduction. ITK is known to not be absolutely required for signaling, but its 
activity helps amplify PLC-ɣ1 activation and enhance the fitness of T cell 
activation overall (Andreotti et al., 2010). Experiments here expose the 
complex behaviors among separate signaling pathways. Pathways can be 
ordered into a pseudo-hierarchy of ITK dependency: NF-κB signaling 
benefitting most, then NFAT, and lastly Erk1/2 (MAPK) activation. Flipping 
this hierarchy around, one can imagine that this represents a priority of early 
T cell activation requirements, where digital activation of MAPK and NFAT 
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are absolutely required and NF-κB is supplemented gradually to tune the 
response. 
 The experimental results in Chapter III support ideas permeating 
much of the current literature about T cell activation. They suggest that TCR 
triggering and much of downstream pathway activation is digital. Digital 
MAPK activation is well understood and bimodal patterns of NFAT 
translocation are clear (Das et al., 2009; Gallagher et al., 2018). When 
stimulating a pool of clonal cells like OT-I, fractional all-or-none responses 
represent individual cells switching on when passing a signaling threshold. 
For Erk1/2 activation it is a threshold of proximal TCR triggering and Ras 
activity that ignites positive feedback on SOS (Das et al., 2009). Opening of 
Ca2+ channels during SOCE rapidly spike intracellular Ca2+ levels and NFAT1 
quickly responds (Trebak and Kinet, 2019). 
 In previous studies, NF-κB was reported to display digital activation 
behavior (Kingeter et al., 2010). Therefore the revelation that NF-κB displays 
analog behavior within digitally NFAT and Erk1/2 activated OT-I cells in 
response to graded TCR stimulation or ITK inhibition was unexpected. In my 
experiments, 100 nM of moderate affinity T4 peptide induced a maximum 
proportion of NFAT1 responders similar to N4 peptide, albeit at slower rate of 
conversion. NF-κB translocation was consistently inefficient under T4 
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stimulation conditions. Similar differential effects were observed when cells 
were treated with PRN-694. 
 The mechanism regulating graded NF-κB signaling is not fully explored 
here. Different from the Ca2+/NFAT pathway and the cascade of MAPK 
signaling, NF-κB proteins are normally inhibited by IκB proteins during 
steady state (Cheng et al., 2011; Lucas et al., 2004). The rate of 
ubiquitinylation and degradation of IκB⍺ may limit the rate of NF-κB release. 
The half-life of IκB⍺ has been measured as long as 138 minutes in resting 
cells, but a 1.5 minutes in strongly stimulated cells (Henkel et al., 1993; 
Kanarek et al., 2010; Whiteside et al., 1997). In Jurkat cell lines, IκB⍺ 
degradation can take up to 15 minutes following PMA/ionomycin stimulation. 
While rapid and bimodal IκB⍺ degradation has been achieved in Jurkat cells 
and OT-II cells, the panel of stimulation conditions tested here have carefully 
revealed incomplete and graded states of early NF-κB signaling (Kingeter et 
al., 2010). Further, OT-I cells consistently displayed signs of NFAT1 activation 
almost immediately (less than 5 minutes), while NF-κB was more delayed, 
with weakly stimulated cells only achieving appreciable NF-κB nuclear 
protein content after 60 minutes. Whether weak peptide stimulation or ITK 
inhibition regulate the half-life of IκB could be tested in future studies. 
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 NF-κB signaling was specifically sensitive to PRN-694 treatment. This 
indicated a role for ITK in boosting signals from weaker TCR inputs that 
could not sufficiently trigger NF-κB on their own, even under conditions that 
stimulate NFAT and Erk. Later during activation, after initial priming, 
combined TCR, CD28, and other co-stimulatory receptors become 
increasingly important in amplifying NF-κB signaling via PI3K (Chen and 
Flies, 2013). It may be advantageous for naive cells to ‘protect’ NF-κB, by 
making it more difficult to trigger with TCR stimulus alone. In a lymph node, 
instead of pools of clones stimulated with the same peptide, lone clones must 
scan activated APCs to compete for the best combination of antigen quality 
and concentration (Henrickson et al., 2008; Mempel et al., 2004). Slower NF-
κB induction would make it more difficult for T cells to commit to the full 
activation transcriptional trajectory and allow for increased T cell scanning 
periods to accumulate early gene products such as c-Fos and c-Myc, which 
ultimately contribute to the scale of the effector response (Clark et al., 2011; 
Mayya and Dustin, 2016; Preston et al., 2015).  
 While ITK helps amplify PLC-ɣ1 production of DAG and IP3 
concentration to more effectively induce NF-κB, to combat unchecked NF-
κB activation in naive cells, negative feedback dynamically regulates NF-κB 
efficiency as a transcription factor (Cheng et al., 2011; Smith-Garvin et al., 
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2009). After N4 stimulation, I measured rapid induction of NF-κB inhibitor 
Nfkbia (IκB⍺) mRNA, which when translated can re-engage NF-κB and cause 
nuclear export. Also induced were Nfkbid, and Nfkbiz, mediators of p65 
transcriptional activity and Tnfaip3 (A20), a deubiquitinase known to inhibit 
NF-κB signaling and a target of NF-κB transcription (Annemann et al., 2016; 
Krikos et al., 1992; Wertz et al., 2004). Transcripts of all of these indicators of 
strong NF-κB signaling were significantly reduced in PRN-694 treated cells. 
 Based on the results in chapter III from PMA and ionomycin 
stimulation, it is clear that both DAG and IP3 activation are required for 
optimal NF-κB translocation in naive cells. Strong N4 peptide sufficiently 
activated p-Erk1/2 and NFAT, but only partially activated NF-κB. RNA-seq 
and ATAC-seq evidence also suggested treatment with PRN-694 specifically 
dampened NF-κB associated early gene transcription. This highlights a 
unique role for ITK. My first hypotheses about how ITK regulated signaling 
included it tuning the Ca2+ effects of IP3 signaling. However, this line of 
thinking is inaccurate. ITK sits upstream of PLC-ɣ1, and its activity influences 
equimolar production of DAG and IP3; weaker TCR signaling and lower ITK 
activity reduce both DAG and IP3 similarly. What my results demonstrate is 
that the nuance of ITK control of graded signaling is rooted in the fact that 
NFAT, Erk1/2, and NF-κB pathways each respond differently to changing 
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DAG and IP3 concentrations. NF-κB proved to be most complex; sensitive to 
the synergistic effects of both DAG and the IP3. This defines a role for ITK 
beyond lowering the digital signaling thresholds of NFAT and Erk1/2, but also 
improves stubborn NF-κB activation in naive cells.  
How TCR signal strength scales the effector response 
 Two basic underlying questions were driving my research goals in 
understanding TCR control of CD8+ T cell activation: How do digital signals 
produce graded gene expression? And, to what extent do graded signals, 
such as those capable through NF-κB, contribute to graded gene expression?  
 The experiments presented here outline an interesting role for NF-κB, 
and indirectly ITK, as mechanisms to influence graded gene expression. Yet, 
evidence supporting graded NF-κB signaling behavior does not fit the same 
mold as other aspects of early TCR signaling. Numerous studies describe TCR 
proximal triggering and activation of the majority of downstream pathways 
as digital processes (Au-Yeung et al., 2014; Das et al., 2009; Huang et al., 2013; 
Kingeter et al., 2010; Podtschaske et al., 2007). This means that in a pool of 
clonal cells, a growing fraction of cells “switches on” over time and within 
each cell there are no intermediate states of signaling, similar to the behavior 
of NFAT and Erk1/2 that I observed. The importance of NF-κB transcriptional 
activity in regulating T cell activation programming is clear, but graded NF-
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κB transcriptional activity is likely not the only or primary rheostat to scale 
the response. 
 Digital TCR triggering and digital signals are converted to graded gene 
expression within the first few hours of stimulation. TCR signaling and ITK-
dependent expression of IRF4 within 24 hours is a well-studied example of a 
graded activation-associated gene (Conley et al., 2020; Huber and Lohoff, 
2014; Man et al., 2013; Nayar et al., 2014). Much of the focus on IRF4 is 
because its transcriptional activity is critical in directing the further graded 
expression of important regulators of metabolic T cell reprogramming (Man 
et al., 2013). Incremental amounts of IRF4 protein can be detected as early as 
four hours after stimulation, and RNA-seq results here detected Irf4 
transcripts within 2 hours. Yet other activation-associated gene products 
also are induced at graded amounts in response to graded TCR signaling. 
BATF, a frequent binding partner for IRF4, is induced at a similar time and has 
been found that its expression is also linked to TCR stimulation strength 
(Iwata et al., 2017; Kurachi et al., 2014). Expression of CD25, the IL-2R alpha-
chain, is also proportional to peptide affinity when measured by FACS 
(Conley et al., 2020). In my own RNA-seq results, Il2ra, Il2, and Ifng transcript 
abundance (as well as most of the genes found in later induced clusters) were 
beginning to display graded patterns of expression reflecting variable TCR 
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signal conditions. Digital signal integration may occur during a temporal 
window of early gene product accumulation. 
 A major factor thought to convert digital biochemical processes to 
analog gene responses is the duration of TCR signaling (Mayya and Dustin, 
2016; Tkach and Altan-Bonnet, 2013). In vivo, T cells first enter a scanning 
phase of making and breaking contacts with APCs (Mempel et al., 2004). Cells 
that encounter weaker affinity or lower concentration of antigen spend more 
time in the scanning phase (Henrickson et al., 2008; Mempel et al., 2004). 
Stronger TCR interactions lead to a shorter scanning phase. One study 
demonstrated T cells can sum antigen experiences from serial interactions 
with APCs. By intermittently interrupting T cell and APC contacts with a Src 
kinase inhibitor, they found IFN-gamma production was directly proportional 
to the total duration that T cells were engaged (Faroudi et al., 2003). To 
facilitate signal summation, a hysteresis period characteristic in MAPK 
activation and the relatively slow rate of NFAT export signaling behaviors 
that dampen the detrimental effects of antigen withdrawal and allow for 
signal “memory” (Das et al., 2009; Marangoni et al., 2013). 
 To explore graded induction mechanisms that lie beyond signal 
memory, others created molecular models to provide insights into how 
intermittent digital T cell signaling could produce slow accumulation of early 
gene products, like the AP-1 member c-Fos (Locasale, 2007). They 
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determined this behavior was plausible, and a later study showed c-Fos 
accumulation in vivo was able to reflect the summation of serial T cell 
stimulations (Clark et al., 2011). In the experiments presented here, ITK or 
NF-κB inhibition consistently reduced the accumulation of c-Fos protein 
within the first few hours after activation. The data do not indicate whether 
this reflects shorter duration of TCR engagement or some kind of throttled 
signaling (e.g. graded NF-κB) within individual cells. Because the in vitro 
stimulation methods tested here do not adequately simulate a lymph node 
environment, future experiments should test whether ITK activity dampens 
c-Fos accumulation due to reduced cell intrinsic signal intensity or due to 
producing longer, more intermittent signal duration. This may be possible 
using a combination of approaches that image live cell lymph nodes after OT-
I adoptive transfer and peptide injection, as well as ex vivo FACS examination 
of T cells stimulated in vivo. These experiments would also compliment those 
proposed in the Chapter III Discussion, as it is still unclear how ITK activity 
regulates the duration of the T cell scanning period. 
 Accumulation of early gene products may linearly regulate later, 
secondary graded gene expression. Il2 transcripts were one of the most 
differentially expressed when OT-I cells were inhibited with PRN-694. The 
same signaling conditions produced deficient AP-1 activity (decreased Fos, 
Fosb) and decreased NF-κB activation. The Il2 promoter contains multiple 
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functional AP-1 and NF-κB sites, which could explain poor Il2 induction. (Jain 
et al., 1995; Jain et al., 1992). Increased dose of nuclear NF-κB (p65) in naive 
cells likely is a major activator of early Il2 expression (as a p50-p65 
homodimer) (Jain et al., 1995). Further, later graded expression of induced 
NF-κB protein c-Rel responds to continued TCR signals and becomes 
increasing important in acting on the Il2 promoter and scaling IL-2 
expression. 
 IL-2 is a potent cell survival cytokine during activation. IL-2 signals 
sum with TCR signaling inputs to regulate the number of cell divisions T cells 
undergo during expansion (Marchingo et al., 2014). IL-2 signaling was found 
to sustain the expression of the early induced transcription factor c-Myc 
(Heinzel et al., 2016; Preston et al., 2015). As observed by myself and others, c-
Myc is induced quickly after TCR engagement and exhibits strong digital 
expression patterns. In my experiments, after 6 hours, regardless of peptide 
stimulation or ITK inhibition, all OT-I cells were converging on their c-Myc 
expression phenotype. IL-2 signaling prolonged the duration that c-Myc was 
maintained after digital induction. This correlated directly with number of 
cell divisions clones underwent (Heinzel et al., 2016). Cells that did not 
receive IL-2 supplementation lost degraded c-Myc more rapidly and ceased 
dividing sooner. This is an example of how early AP-1 and NF-κB activity, 
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which regulate IL-2, can lead to large differences in the scale of the T cell 
effector pool. 
 The Berg lab and others have utilized CD69 as a digital marker for T 
cell activation (Conley et al., 2020). CD69 has been directly associated with 
Erk1/2 activation, which is decidedly digital in behavior (Altan-Bonnet and 
Germain, 2005; Das et al., 2009). Yet, CD69 expression is not always 
indicative of a fully activated T cell. In fact, cells that are similarly CD69+ can 
display varying states of other markers of activation. A study of “suboptimal” 
signaling conditions demonstrated when Lck-/- OT-I cells were stimulated 
with N4 peptide, all cells switched on CD69 similarly, but were severely 
deficient in ribosome biogenesis, proliferative capacity, cell size, and had 
decreased expression of Il2ra, Bcl2l1 (Bcl-XL), Myc, and Ifng (Tan et al., 2017). 
c-Myc is a key regulator of the global transcription rate, thus important in 
scaling graded responses within individual cells (Dang, 2013). IL-2 
supplementation during weak G4 peptide stimulation increased c-Myc 
expression present at 72 hours and increased cell proliferation rate and 
ribosome biogenesis (Tan et al., 2017). These signaling conditions test weak 
TCR interactions and highlight potentially hidden graded states within 
“activated” cells. Likely, graded expression of IRF4 is more representative of 
the global relative induction of transcripts within activating CD8+ T cells; 
gradual accumulation of early gene product that begins immediately after 
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TCR engagement has powerful influence over the scale of the CD8+ T cell 
response.  
Significance of TCR signal strength and ITK activity in disease 
 The precise measurement of TCR signaling pathways and their 
immediate transcriptional effects described here have revealed important 
details about the relationship of NFAT, NF-κB and MAPK activation in naive 
CD8+ T cells. Specifically, robust NF-κB activation requires ample TCR 
signaling conditions and the assistance of ITK activity. This has implications 
in understanding human disease states and applications that require detailed 
control of TCR signals to achieve specific T cell functions, population 
expansion, and cytotoxic target cell killing. This includes response to 
pathogens, function and trafficking of autoimmune T cells, and anti-tumor T 
cell behavior. Tuning TCR signals and ITK activity to elicit specific control of 
NF-κB pathways during early activation and effector cell functions may be an 
important factor in optimizing the efficacy and success of T cell-mediated 
medicine. 
 Early experiments investigating the function of ITK suggested that it 
may have had an important role in permitting T cell responses to allergic 
diseases. Balb/c mice notably have CD4+ helper T cell responses skewed 
toward classic type 2 (TH2) profiles. However Balb/c Itk-/- mice did not 
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mount a TH2 response to Leishmania major, Nippostrongylus brasiliensis, or 
Schistosoma mansoni parasitic infections. Perhaps this was due to 
insufficient NFAT activation of IL-4 production to assist in TH2 differentiation 
(Andreotti et al., 2010; Fowell et al., 1999; Schaeffer et al., 2001). It is unclear 
however, whether low production of TH2 cells in Itk-/- mice was due to 
reduction of responding activating T cells or weakened tuned TCR signaling 
within activated cells which could alter patterns in function and 
differentiation. Based on the data presented here, it would be relevant to 
investigate whether tuned TCR signals, including graded NF-κB signaling, 
also play a role in ITK-dependent TH2 responses.  
 In the Balb/c Itk-/- parasitic infection models discussed above, CD4+ T 
cells were still able to differentiate towards TH1 fates, often sufficient enough 
to clear infection. Itk-/- T cells also displayed differential expression of 
another Tec family kinase, Rlk, which was higher in TH1 cells and likely 
contributed to signal amplification more readily than in TH2 (Miller et al., 
2004). Supplemental ectopic Rlk expression in Itk-/- mice was sufficient to 
restore TH2 responses to Schistosoma mansoni eggs or airway allergy models 
(Sahu et al., 2008). This series of experiments exemplified the important 
redundancy of the Tec kinase family within T cell signaling machinery, but 
also that specific T cell subsets may rely more on ITK for signal amplification 
than others. Further, these experiments show germ line Itk-/- mice may 
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display phenotypes that are a result of different developmental conditions 
across different T cell types, rather than the specific contribution of ITK to 
graded signal transduction within single cells. The ITK inhibitor used in my 
experiments, PRN-694, inhibits the activity of both ITK and Rlk, thus I would 
expect it would have broader effects on both TH1 and TH2 responses during 
infection. Development of conditional Itk knockout mice, under control of a 
tamoxifen-inducible T cell-specific promoter (e.g. CD4), could more precisely 
evaluate ITK contribution to disease phenotypes. 
 There are specific examples of ITK-associated pathology in humans. In 
2009, it was reported homozygous Itk deficiency in two sibling girls was fatal 
in the context of Epstein-Bar virus (EBV) infection (Huck et al., 2009). The 
patients exhibited high eomesodermin expression in CD8+ T cell populations, 
indicative of inefficient effector T cell expansion, and also lacked natural 
killer (NK)T cell populations. These phenotypes combined likely contributed 
to uncontrolled EBV replication. After years of evidence gathered from 
mouse models describing the importance of ITK in TCR signal transduction, 
this confirmed a critical role for ITK in signal amplification during CD8+ T cell 
responses in humans. 
 ITK is also important in regulating T cell function and trafficking 
during autoimmune disease. T cells lacking the co-inhibitory receptor 
CTLA-4, which counteracts the activating, signal-amplifying effects of CD28 
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co-stimulation, are unable to maintain tolerance to self and develop a fatal 
accumulation of self-specific T cells that infiltrate the periphery (Ise et al., 
2010). In humans, polymorphisms in Ctla4 are linked to autoimmune disease 
states (Gough et al., 2005). Interestingly, Ctla4-/- Itk-/- double knockout mice 
do not develop disease, accumulating self-reactive T cells in lymphoid organs 
that are unable to migrate to the periphery (Jain et al., 2013). This 
phenomenon highlighted the important role for ITK balancing TCR and CD28 
signal summation. It also suggested that signal amplification due to ITK 
activity is important in regulating cell migration machinery or programming.  
 In a separate study, ITK inhibition with PRN-694 reduced T cell 
infiltration and disease progression of a colitis model in mice. PRN-694 
inhibition blocked TH1 and TH17 differentiation and also reduced their ability 
migrate toward inflammatory cytokines in vitro (Cho et al., 2015). Itk-/- mice 
also displayed defects in steady-state CD4+ and CD8+ T cell populations, with 
decreased homing-receptor expression, highlighting the role of ITK-
mediated signaling in regulating T cell function in the periphery (Cho et al., 
2020). Thus, beyond the role of amplifying TCR signals during naive CD8+ T 
cell priming as analyzed in this dissertation, ITK is a critical component of 
TCR-directed signaling in terminal cell states to appropriately balance T cell 
tolerance to self and responses to pathogenic challenges. 
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 Precise control of TCR signals is an exciting focus to progress the 
development of successful therapeutics against human cancers. Tumor 
infiltrating CD8+ T cells make up a critical component of tumor infiltrating 
lymphocytes (TILs) that assist in control of malignancies and target tumor 
cell killing. However, a combination of immune evasion tactics by cancer cells 
and chronic activity of CD8+ T cell populations create significant obstacles 
that oppose efficient eradication of disease. 
 During both chronic viral infections and when challenged by 
malignancies, persistent exposure to antigen and inhibitory receptor 
stimulation pushes CD8+ T cell populations to progressively exhibit signs of T 
cell exhaustion (Wherry and Kurachi, 2015). High expression of PD-1 and 
CTLA-4 on the surface of CD8+ T cells, prescribed by specific induced T cell 
exhaustion transcriptional programming, work to dampen TCR signaling and 
inhibit the proliferative potential and cytokine production of T cell 
populations (Chen and Flies, 2013; Wherry and Kurachi, 2015). Cancer cells 
often express PD-1 ligands (PD-L1, PD-L2) which interact with PD-1-high T 
cells to inhibit function. CTLA-4 interacts with B7 molecules on tumor cells 
to inhibit T cell co-stimulation. Thus, CTLA-4 and PD-1 pathways were the 
initial core targets for checkpoint blockade immunotherapies.  
 Treatment with a combination of anti-CTLA-4 and anti-PD-1 
antibodies block the their inhibitory effects and rescue T cell anti-tumor 
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functions, which have been exceptionally successful in treating certain 
cancers, including some melanomas, non-small cell lung carcinomas 
(NSCLC), urothelial bladder cancers, and triple-negative breast cancers 
(TNBC) (Darvin et al., 2018; Pardoll, 2012). However, patient response to 
checkpoint inhibitors differs greatly. Individual tumor microenvironments 
can exhibit polarized degrees of immunogenicity, from highly inflammatory, 
which promotes T cell exhaustion phenotypes, to “immune deserts,” which 
present low amounts of antigen and co-stimulatory molecules, evading T cell 
priming and target killing, promoting tolerance of the tumor (van der Leun et 
al., 2020). Beyond checkpoint inhibitors, next generation of immunotherapies 
will have to consider a dynamic range of TCR signaling conditions; from 
persistent, exhaustion-promoting signals to suboptimal, anergy-promoting 
signals. 
 Chimeric antigen receptor (CAR) T cells are another promising 
therapeutic tool to target human cancer cells. CAR T cells express 
engineered TCRs made up of cytoplasmic signaling domain components of 
the the TCR, such as CD3-𝜁, fused with varied tumor epitope-specific 
extracellular domains such as antibody variable regions (Maldini et al., 2018). 
Therefore, new insights about how TCR signal strength and ITK activity 
balance downstream signal pathways are pertinent to help improve CAR T 
cell technologies. Patient-derived T cells transduced to express a CAR 
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specific for CD19 led to up to 90% remission in children with acute 
lymphoblastic leukemia (ALL) (Davila et al., 2014; Maude et al., 2014). While 
blood cancers respond well to CAR T cell therapeutics, exhaustion of CAR T 
cells presents greater challenges for effective killing of solid tumors.  
 Recent work revealed NR4A family transcription factors, which are 
regulated by persistent, prolonged NFAT signaling, actively regulate T cell 
exhaustion programming and limit NF-κB and AP-1 signals, (Martinez et al., 
2015; Mognol et al., 2017; Scott-Browne et al., 2016). In an effort to increase 
the efficacy and reduce exhaustion of CAR T cells, one study infused human 
CD19-directed CAR T cells that lacked Nr4a family genes into mice with B16 
tumors expressing human CD19 (Chen et al., 2019). Nr4a triple knockout 
human CD19 mouse CAR T cells promoted tumor regression, animal survival, 
and exhibited increased CAR T effector transcriptional profiles. Genomic 
accessibility assays showed Nr4a triple knockout CAR T cells were enriched 
for NF-κB and AP-1 motifs, while wild type CAR T cells were enriched for 
NFAT and Nr4a3 motifs. These results reiterate that effective CAR T cell 
target killing, and overcoming general phenotypes of T cell exhaustion, 
requires signaling conditions that balance steady NFAT signaling while also 
robustly engaging NF-κB and AP-1.  
 The importance of ITK signaling within tumor-specific T cells and T 
cell immunotherapies is not fully understood. As presented here, ITK activity 
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permits more robust activation of NF-κB and production of AP-1-associated 
transcription factors in naive cells. Precisely regulating ITK activity in the 
clinic will be challenging. A greater understanding about how to finely 
increase or decrease ITK activity may require novel approaches to tune the 
balance of TCR signaling needed to optimize the efficacy of patient natural 
TILs and ex vivo patient-derived CAR T cell therapeutics. High ITK activity 
and intense TCR signaling begins to stimulate cell death pathways. Selection 
of CAR designs should be uniquely chosen for individual cancers. Eradication 
of evasive “immune desert” tumors, which have low MHC/antigen and co-
stimulatory molecules, may benefit from increased ITK activation to assist in 
TIL priming or to maximize CAR T expansion. Tumors that are particularly 
immunogenic may quickly promote exhausted tumor-specific T cells, thus it 
is necessary to test whether increased ITK activity could recover NF-κB and 
AP-1 signals within T cells that experience disproportionate NFAT signaling.  
 Conversely, use of ibrutinib, an inhibitor of both B cell-expressed 
Bruton’s tyrosine kinase (BTK) and ITK, has shown reducing ITK activity can 
improve T cell anti-tumor functions. In two separate studies, ibrutinib 
administration to chronic lymphocytic leukemia (CLL) patients provided a 
marked increase of CD4+ and CD8+ tumor-specific T cells and engrafted CAR 
T cells, with reduced expression of CTLA-4 and PD-1 (Fraietta et al., 2016; 
Long et al., 2017). Expansion of patient-derived CAR T cells also had increased 
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proliferation and exhibited fewer markers for exhaustion (e.g. PD-1, TIM-3, 
LAG-3 ) when expanded in the presence of ibrutinib (Fan et al., 2021). It is 
possible that weakened TCR signals may push fewer cells into towards cell 
death pathways. Use of a more potent specific inhibitor of ITK, such as 
PRN-694 may prove to further optimize expansion of CAR T cells.  
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